[
  {
    "id": 182889,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23664,
      "drug_code": 86282,
      "updated_date": "2025-05-15T04:19:41-04:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8351016,
          "ingredient": {
            "id": 2920,
            "ingredient_code": 12335,
            "en_name": "INSULIN ASPART",
            "fr_name": "Insuline asparte"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02377209",
      "brand_name": "NOVORAPID",
      "brand_name_fr": "",
      "descriptor": "FLEXTOUCH 3ML PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144802001"
    },
    "created_date": "2023-02-01T15:24:47-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02377209",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "discontinuation_date": "2023-08-16T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Patients who continue to have coverage for NovoRapid® FlexTouch® have the option to transition to the Penfill® format with NovoPen® 4, our durable insulin device that is available free-of-charge for patients at the pharmacy.",
    "fr_discontinuation_comments": "Les patients qui continuent de bénéficier d'une couverture pour les formats NovoRapid® FlexTouch® ont la possibilité de passer au format Penfill® avec NovoPen® 4, notre dispositif d'insuline durable qui est gratuitement mis à disposition pour les patients en pharmacie.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-08-17T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NOVORAPID",
    "en_drug_common_name": "NOVORAPID FLEXTOUCH 100U 5X3ML",
    "fr_drug_brand_name": "NOVORAPID",
    "fr_drug_common_name": "NOVORAPID FLEXTOUCH 100U 5X3ML",
    "en_ingredients": "INSULIN ASPART",
    "fr_ingredients": "Insuline asparte",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "EA",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 182902,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27514,
      "drug_code": 89748,
      "updated_date": "2025-05-15T04:21:37-04:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8353676,
          "ingredient": {
            "id": 3252,
            "ingredient_code": 13104,
            "en_name": "INSULIN DETEMIR",
            "fr_name": "Insuline détemir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02412829",
      "brand_name": "LEVEMIR FLEXTOUCH",
      "brand_name_fr": "",
      "descriptor": "PREFILLED PEN-INJECTOR (3ML CARTRIDGE)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151541001"
    },
    "created_date": "2023-02-01T15:44:36-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02412829",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "A10AE",
    "atc_description": "INSULINS AND ANALOGUES",
    "discontinuation_date": "2023-08-04T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Patients who continue to have coverage for Levemir® FlexTouch® formats have the option to transition to the Penfill® format with NovoPen® 4, our durable insulin device that is available free-of-charge for patients at the pharmacy.",
    "fr_discontinuation_comments": "Les patients qui continuent de bénéficier d'une couverture pour les formats Levemir® FlexTouch® ont la possibilité de passer au format Penfill® avec NovoPen® 4, notre dispositif d'insuline durable qui est gratuitement mis à disposition pour les patients en pharmacie.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-08-07T13:48:55-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LEVEMIR FLEXTOUCH",
    "en_drug_common_name": "LEVEMIR FLEXTOUCH 5X3 ML",
    "fr_drug_brand_name": "LEVEMIR FLEXTOUCH",
    "fr_drug_common_name": "LEVEMIR FLEXTOUCH 5X3ML",
    "en_ingredients": "INSULIN DETEMIR",
    "fr_ingredients": "Insuline détemir",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "EA",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 182907,
    "drug": {
      "current_status": "MARKETED",
      "id": 30644,
      "drug_code": 9269,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251139,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716634",
      "brand_name": "BETADERM LOTION 0.1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68221",
      "number_of_ais": "1",
      "ai_group_no": "0106299001"
    },
    "created_date": "2023-02-01T15:58:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716634",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2023-04-07T00:00:00-04:00",
    "actual_start_date": "2023-01-16T00:00:00-05:00",
    "actual_end_date": "2023-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-07T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BETADERM LOTION 0.1%",
    "en_drug_common_name": "BETADERM",
    "fr_drug_brand_name": "BETADERM LOTION 0.1%",
    "fr_drug_common_name": "BETADERM",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "75",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 182958,
    "drug": {
      "current_status": "MARKETED",
      "id": 101938,
      "drug_code": 100560,
      "updated_date": "2021-06-08T05:13:14-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266311,
          "ingredient": {
            "id": 800,
            "ingredient_code": 9197,
            "en_name": "SODIUM BICARBONATE",
            "fr_name": "Bicarbonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "84",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02516225",
      "brand_name": "SODIUM BICARBONATE INJECTION USP",
      "brand_name_fr": "BICARBONATE DE SODIUM POUR INJECTION USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104153005"
    },
    "created_date": "2023-02-01T16:39:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02516225",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-01T00:00:00-05:00",
    "actual_end_date": "2023-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-25T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM BICARBONATE INJECTION USP",
    "en_drug_common_name": "Sodium Bicarbonate Injection USP",
    "fr_drug_brand_name": "Bicarbonate de sodium pour injection USP",
    "fr_drug_common_name": "Bicarbonate de sodium pour injection USP",
    "en_ingredients": "SODIUM BICARBONATE",
    "fr_ingredients": "Bicarbonate de sodium",
    "drug_strength": "84MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10x50mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 182969,
    "drug": {
      "current_status": "MARKETED",
      "id": 10792,
      "drug_code": 66607,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254081,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242784",
      "brand_name": "MYLAN-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506002"
    },
    "created_date": "2023-02-01T18:19:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242784",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2023-03-14T00:00:00-04:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-20T17:30:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 182986,
    "drug": {
      "current_status": "MARKETED",
      "id": 50674,
      "drug_code": 94597,
      "updated_date": "2025-05-15T02:35:40-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262189,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458926",
      "brand_name": "MYLAN-DIVALPROEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996004"
    },
    "created_date": "2023-02-01T18:28:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458926",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2023-02-10T00:00:00-05:00",
    "actual_start_date": "2023-02-04T00:00:00-05:00",
    "actual_end_date": "2023-02-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-14T18:33:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-DIVALPROEX",
    "en_drug_common_name": "MYLAN-DIVALPROEX",
    "fr_drug_brand_name": "MYLAN-DIVALPROEX",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "125MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)\r\nTABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)\r\nComprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 182999,
    "drug": {
      "current_status": "MARKETED",
      "id": 31938,
      "drug_code": 9448,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251168,
          "ingredient": {
            "id": 54,
            "ingredient_code": 8523,
            "en_name": "GRAMICIDIN",
            "fr_name": "Gramicidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251167,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": true
        },
        {
          "id": 8251166,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251165,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00717002",
      "brand_name": "VIADERM KC CRM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68586",
      "number_of_ais": "4",
      "ai_group_no": "0405625002"
    },
    "created_date": "2023-02-01T18:31:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00717002",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07CB",
    "atc_description": "CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",
    "estimated_end_date": "2023-02-24T00:00:00-05:00",
    "actual_start_date": "2023-01-26T00:00:00-05:00",
    "actual_end_date": "2023-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-28T22:28:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VIADERM KC CRM",
    "en_drug_common_name": "VIADERM KC",
    "fr_drug_brand_name": "VIADERM KC CRM",
    "fr_drug_common_name": "VIADERM KC",
    "en_ingredients": "NYSTATIN\r\nGRAMICIDIN\r\nNEOMYCIN\r\nTRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Nystatine\r\nGramicidine\r\nNéomycine\r\nAcétonide  de triamcinolone",
    "drug_strength": "100000UNIT\r\n0.25MG\r\n2.5MG\r\n1MG",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183002,
    "drug": {
      "current_status": "MARKETED",
      "id": 101187,
      "drug_code": 99198,
      "updated_date": "2023-06-19T22:04:45-04:00",
      "company": {
        "id": 17271,
        "created_date": "2023-06-19T22:00:15-04:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 18848,
        "mfr_code": "",
        "name": "BIOSIMILAR COLLABORATIONS IRELAND LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 35/36",
        "street_name": "GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13",
        "province": "--",
        "country": "IRELAND",
        "city": "DUBLIN",
        "postal_code": "D13R20R",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265421,
          "ingredient": {
            "id": 3168,
            "ingredient_code": 13356,
            "en_name": "ADALIMUMAB",
            "fr_name": "Adalimumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.8",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02502402",
      "brand_name": "HULIO",
      "brand_name_fr": "",
      "descriptor": "SINGLE-DOSE PREFILLED PENS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150364003"
    },
    "created_date": "2023-02-01T18:33:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02502402",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "L04AB",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2023-02-02T00:00:00-05:00",
    "actual_start_date": "2023-01-18T00:00:00-05:00",
    "actual_end_date": "2023-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-02T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HULIO",
    "en_drug_common_name": "ADALIMUMAB",
    "fr_drug_brand_name": "HULIO",
    "fr_drug_common_name": "ADALIMUMAB",
    "en_ingredients": "ADALIMUMAB",
    "fr_ingredients": "Adalimumab",
    "drug_strength": "40MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2 x 0.8mL sterile solution subcutaneous injection (PEN) (40mg/0.8mL)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183064,
    "drug": {
      "current_status": "MARKETED",
      "id": 24006,
      "drug_code": 86648,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258638,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380706",
      "brand_name": "TARO-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2023-02-01T21:16:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380706",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2023-09-26T00:00:00-04:00",
    "actual_start_date": "2023-01-26T00:00:00-05:00",
    "actual_end_date": "2023-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-09-25T20:41:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "TARO-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183077,
    "drug": {
      "current_status": "MARKETED",
      "id": 17846,
      "drug_code": 78902,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256262,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303728",
      "brand_name": "TARO-CIPROFLOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207006"
    },
    "created_date": "2023-02-01T21:23:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303728",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2023-02-01T00:00:00-05:00",
    "actual_end_date": "2024-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-09T20:38:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CIPROFLOX",
    "en_drug_common_name": "CIPROFLOX",
    "fr_drug_brand_name": "TARO-CIPROFLOX",
    "fr_drug_common_name": "CIPROFLOX",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183082,
    "drug": {
      "current_status": "MARKETED",
      "id": 17850,
      "drug_code": 78904,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256264,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303744",
      "brand_name": "TARO-CIPROFLOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207002"
    },
    "created_date": "2023-02-01T21:26:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303744",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2023-02-01T00:00:00-05:00",
    "actual_end_date": "2024-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-09T20:37:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CIPROFLOX",
    "en_drug_common_name": "CIPROFLOX",
    "fr_drug_brand_name": "TARO-CIPROFLOX",
    "fr_drug_common_name": "CIPROFLOX",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183168,
    "drug": {
      "current_status": "MARKETED",
      "id": 66073,
      "drug_code": 81550,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 12493,
        "created_date": "2019-06-14T02:15:03-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 17542,
        "mfr_code": "",
        "name": "CURIUM CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "217 & 220",
        "street_name": "2572 BOUL. DANIEL-JOHNSON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2R3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257098,
          "ingredient": {
            "id": 13857,
            "ingredient_code": 12391,
            "en_name": "TETRAKIS [CU",
            "fr_name": "TETRAKIS [CU(MIBI)4]BF4"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02329794",
      "brand_name": "KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152590001"
    },
    "created_date": "2023-02-02T13:26:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329794",
    "company_name": "CURIUM CANADA INC",
    "atc_number": "V09GA",
    "anticipated_start_date": "2023-02-02T00:00:00-05:00",
    "estimated_end_date": "2023-02-20T00:00:00-05:00",
    "actual_start_date": "2022-02-02T00:00:00-05:00",
    "actual_end_date": "2023-02-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-02-21T13:05:39-05:00",
    "status": "resolved",
    "en_comments": "Kit for the Preparation of Technetium Tc 99m Sestamibi Injection has been depleted prior to release of the next lot. Inventory replenishment is expected by Monday, Feb 20, 2023.\r\nWe understand the inconvenience this may cause you and apologize for the disruption.",
    "fr_comments": "Les quantités du  Kit pour la préparation de l'injection de technetium Tc 99m Sestamibi sont épuisées avant la sortie du prochain lot.\r\nLe réapprovisionnement des stocks est prévu d'ici le 20 février.\r\nNous comprenons les désagréments que cela peut vous occasioinner et nous nous excusons de la perturbation.",
    "en_drug_brand_name": "KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION",
    "en_drug_common_name": "kit for the prepration of technetium tc 99m sestamibi injection",
    "fr_drug_brand_name": "Trousse pour la préparation de l'injection de sestamibi-technetium Tc 99m",
    "fr_drug_common_name": "Trousse pour la préparation de l'injection de sestamibi-technetium Tc 99m",
    "en_ingredients": "TETRAKIS [CU",
    "fr_ingredients": "[Tétrafluoroborate de tétrakis (2-méthoxy-isobutyl isonitrile) cuivre (I)]",
    "drug_strength": "1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ml vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183173,
    "drug": {
      "current_status": "MARKETED",
      "id": 29340,
      "drug_code": 91345,
      "updated_date": "2025-12-03T00:32:39-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260640,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429012",
      "brand_name": "DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2023-02-02T14:44:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429012",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2023-04-15T00:00:00-04:00",
    "actual_start_date": "2023-02-02T00:00:00-05:00",
    "actual_end_date": "2023-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-04-26T18:58:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DUTASTERIDE",
    "en_drug_common_name": "Dutasteride",
    "fr_drug_brand_name": "Dutasteride",
    "fr_drug_common_name": "Dutasteride",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183176,
    "drug": {
      "current_status": "MARKETED",
      "id": 25064,
      "drug_code": 87576,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259086,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259085,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390310",
      "brand_name": "TELMISARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783002"
    },
    "created_date": "2023-02-02T14:48:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390310",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2024-01-04T00:00:00-05:00",
    "actual_start_date": "2023-01-23T00:00:00-05:00",
    "actual_end_date": "2024-02-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-02-03T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TELMISARTAN HCTZ",
    "en_drug_common_name": "Telmisartan HCTZ",
    "fr_drug_brand_name": "Telmisartan HCTZ",
    "fr_drug_common_name": "Telmisartan HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nTELMISARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nTelmisartan",
    "drug_strength": "25MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183206,
    "drug": {
      "current_status": "MARKETED",
      "id": 25064,
      "drug_code": 87576,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259086,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259085,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390310",
      "brand_name": "TELMISARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783002"
    },
    "created_date": "2023-02-02T16:06:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390310",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2024-01-04T00:00:00-05:00",
    "actual_start_date": "2023-02-28T00:00:00-05:00",
    "actual_end_date": "2024-02-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-02-03T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TELMISARTAN HCTZ",
    "en_drug_common_name": "Telmisartan HCTZ",
    "fr_drug_brand_name": "Telmisartan HCTZ",
    "fr_drug_common_name": "Telmisartan HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nTELMISARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nTelmisartan",
    "drug_strength": "25MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183209,
    "drug": {
      "current_status": "MARKETED",
      "id": 30106,
      "drug_code": 92142,
      "updated_date": "2025-05-15T02:34:39-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260967,
          "ingredient": {
            "id": 1568,
            "ingredient_code": 11180,
            "en_name": "CEFAZOLIN",
            "fr_name": "Céfazoline (Céfazoline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02437112",
      "brand_name": "CEFAZOLIN FOR INJECTION",
      "brand_name_fr": "CÉFAZOLINE POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109442005"
    },
    "created_date": "2023-02-02T16:50:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437112",
    "company_name": "STERIMAX INC",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "anticipated_start_date": "2023-02-03T00:00:00-05:00",
    "estimated_end_date": "2023-05-05T00:00:00-04:00",
    "actual_end_date": "2023-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-05-08T12:37:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFAZOLIN FOR INJECTION",
    "en_drug_common_name": "CEFAZOLIN FOR INJECTION",
    "fr_drug_brand_name": "CÉFAZOLINE POUR INJECTION",
    "fr_drug_common_name": "CÉFAZOLINE POUR INJECTION",
    "en_ingredients": "CEFAZOLIN",
    "fr_ingredients": "CÉFAZOLINE",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "25 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183220,
    "drug": {
      "current_status": "MARKETED",
      "id": 20408,
      "drug_code": 81956,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8257216,
          "ingredient": {
            "id": 3440,
            "ingredient_code": 20179,
            "en_name": "SITAGLIPTIN",
            "fr_name": "Sitagliptine (Phosphate de sitagliptine monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257215,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02333872",
      "brand_name": "JANUMET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252656003"
    },
    "created_date": "2023-02-02T17:11:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02333872",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2023-02-06T00:00:00-05:00",
    "estimated_end_date": "2023-02-06T00:00:00-05:00",
    "actual_start_date": "2023-02-02T00:00:00-05:00",
    "actual_end_date": "2023-02-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-07T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JANUMET",
    "en_drug_common_name": "sitagliptin and metformin hydrochloride tablets",
    "fr_drug_brand_name": "JANUMET",
    "fr_drug_common_name": "comprimés de sitagliptine et de chlorhydrate de metformine",
    "en_ingredients": "METFORMIN HYDROCHLORIDE\r\nSITAGLIPTIN",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "1000MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183361,
    "drug": {
      "current_status": "MARKETED",
      "id": 2874,
      "drug_code": 16954,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252178,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01934163",
      "brand_name": "NOVAMOXIN",
      "brand_name_fr": "",
      "descriptor": "SUGAR REDUCED",
      "pediatric_flag": false,
      "accession_number": "79068",
      "number_of_ais": "1",
      "ai_group_no": "0131314003"
    },
    "created_date": "2023-02-02T20:43:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01934163",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2023-07-10T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-07-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-05T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NOVAMOXIN",
    "en_drug_common_name": "NOVAMOXIN 250MG/5ML LS SUS",
    "fr_drug_brand_name": "NOVAMOXIN 250MG/5ML LS SUS",
    "fr_drug_common_name": "NOVAMOXIN 250MG/5ML LS SUS",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "150ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183364,
    "drug": {
      "current_status": "MARKETED",
      "id": 2220,
      "drug_code": 14715,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251991,
          "ingredient": {
            "id": 270,
            "ingredient_code": 2564,
            "en_name": "CLONIDINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de clonidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02046121",
      "brand_name": "TEVA-CLONIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76383",
      "number_of_ais": "1",
      "ai_group_no": "0108891001"
    },
    "created_date": "2023-02-02T20:44:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02046121",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C02AC",
    "atc_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLONIDINE",
    "en_drug_common_name": "CLONIDINE 0.1MG TAB",
    "fr_drug_brand_name": "TEVA-CLONIDINE 0.1MG TAB",
    "fr_drug_common_name": "CLONIDINE 0.1MG TAB",
    "en_ingredients": "CLONIDINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de clonidine",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183367,
    "drug": {
      "current_status": "MARKETED",
      "id": 10774,
      "drug_code": 66536,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254074,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242729",
      "brand_name": "TEVA-DOXAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131431003"
    },
    "created_date": "2023-02-02T20:45:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242729",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2023-04-10T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DOXAZOSIN",
    "en_drug_common_name": "DOXAZOSIN 2MG TAB",
    "fr_drug_brand_name": "TEVA-DOXAZOSIN 2MG TAB",
    "fr_drug_common_name": "DOXAZOSIN 2MG TAB",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "DOXAZOSIN",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183371,
    "drug": {
      "current_status": "MARKETED",
      "id": 8382,
      "drug_code": 579,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250157,
          "ingredient": {
            "id": 574,
            "ingredient_code": 10259,
            "en_name": "CHLORPHENIRAMINE MALEATE",
            "fr_name": "Maléate de chlorphéniramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00021288",
      "brand_name": "TEVA-PHENIRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23698",
      "number_of_ais": "1",
      "ai_group_no": "0100615003"
    },
    "created_date": "2023-02-02T20:46:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00021288",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R06AB",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "estimated_end_date": "2023-05-20T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PHENIRAM",
    "en_drug_common_name": "PHENIRAM 4MG TAB",
    "fr_drug_brand_name": "TEVA-PHENIRAM 4MG TAB",
    "fr_drug_common_name": "PHENIRAM 4MG TAB",
    "en_ingredients": "CHLORPHENIRAMINE MALEATE",
    "fr_ingredients": "Maléate de chlorphéniramine",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183374,
    "drug": {
      "current_status": "MARKETED",
      "id": 1288,
      "drug_code": 12862,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251691,
          "ingredient": {
            "id": 54,
            "ingredient_code": 8523,
            "en_name": "GRAMICIDIN",
            "fr_name": "Gramicidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251690,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251689,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251688,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00550507",
      "brand_name": "TEVA-TRIACOMB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74091",
      "number_of_ais": "4",
      "ai_group_no": "0405625002"
    },
    "created_date": "2023-02-02T20:48:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00550507",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07CB",
    "atc_description": "CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",
    "estimated_end_date": "2023-07-30T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-14T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRIACOMB",
    "en_drug_common_name": "TEVA-TRIACOMB CREAM",
    "fr_drug_brand_name": "TEVA-TRIACOMB CREAM",
    "fr_drug_common_name": "TRIACOMB CREAM",
    "en_ingredients": "GRAMICIDIN\r\nNEOMYCIN\r\nNYSTATIN\r\nTRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Gramicidine\r\nNéomycine\r\nNystatine\r\nAcétonide  de triamcinolone",
    "drug_strength": "0.25MG\r\n2.5MG\r\n100000UNIT\r\n1MG",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183377,
    "drug": {
      "current_status": "MARKETED",
      "id": 8374,
      "drug_code": 5778,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250825,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250824,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00608165",
      "brand_name": "TEVA-OXYCOCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61498",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2023-02-02T20:49:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00608165",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2023-05-30T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OXYCOCET",
    "en_drug_common_name": "OXYCOCET TABS 5MG/325MG",
    "fr_drug_brand_name": "TEVA-OXYCOCET TABS 5MG/325MG",
    "fr_drug_common_name": "OXYCOCET TABS 5MG/325MG",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183380,
    "drug": {
      "current_status": "MARKETED",
      "id": 30366,
      "drug_code": 9242,
      "updated_date": "2025-12-03T00:30:26-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251137,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00782718",
      "brand_name": "TEVA-CARBAMAZEPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68169",
      "number_of_ais": "1",
      "ai_group_no": "0108674001"
    },
    "created_date": "2023-02-02T20:50:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00782718",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AF",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2023-03-20T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CARBAMAZEPINE",
    "en_drug_common_name": "CARBAMAZEPINE 200MG TAB",
    "fr_drug_brand_name": "TEVA-CARBAMAZEPINE 200MG TAB",
    "fr_drug_common_name": "CARBAMAZEPINE 200MG TAB",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183383,
    "drug": {
      "current_status": "MARKETED",
      "id": 32166,
      "drug_code": 9886,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251236,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00842648",
      "brand_name": "TEVA-METOPROLOL",
      "brand_name_fr": "",
      "descriptor": "UNCOATED",
      "pediatric_flag": false,
      "accession_number": "69242",
      "number_of_ais": "1",
      "ai_group_no": "0111923002"
    },
    "created_date": "2023-02-02T20:51:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00842648",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2023-08-20T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-08-18T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-METOPROLOL",
    "en_drug_common_name": "METOPROLOL 50MG UNCOAT TAB",
    "fr_drug_brand_name": "TEVA-METOPROLOL 50MG UNCOAT TAB",
    "fr_drug_common_name": "METOPROLOL 50MG UNCOAT TAB",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183386,
    "drug": {
      "current_status": "MARKETED",
      "id": 12302,
      "drug_code": 70717,
      "updated_date": "2025-05-15T02:31:21-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254534,
          "ingredient": {
            "id": 602,
            "ingredient_code": 1200,
            "en_name": "ZOPICLONE",
            "fr_name": "Zopiclone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246534",
      "brand_name": "TEVA-ZOPICLONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122562002"
    },
    "created_date": "2023-02-02T20:52:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246534",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05CF",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2024-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-06-07T14:00:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ZOPICLONE",
    "en_drug_common_name": "ZOPICLONE 5MG TAB",
    "fr_drug_brand_name": "TEVA-ZOPICLONE 5MG TAB",
    "fr_drug_common_name": "ZOPICLONE 5MG TAB",
    "en_ingredients": "ZOPICLONE",
    "fr_ingredients": "Zopiclone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183389,
    "drug": {
      "current_status": "MARKETED",
      "id": 15568,
      "drug_code": 76240,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255581,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276720",
      "brand_name": "TEVA-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2023-02-02T20:54:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02276720",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2023-03-20T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE 5MG TAB",
    "fr_drug_brand_name": "TEVA-OLANZAPINE 5MG TAB",
    "fr_drug_common_name": "OLANZAPINE 5MG TAB",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183392,
    "drug": {
      "current_status": "MARKETED",
      "id": 15922,
      "drug_code": 76692,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255698,
          "ingredient": {
            "id": 286,
            "ingredient_code": 1204,
            "en_name": "FLUCONAZOLE",
            "fr_name": "Fluconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281279",
      "brand_name": "ACT FLUCONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122529002"
    },
    "created_date": "2023-02-02T20:55:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281279",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2024-02-10T00:00:00-05:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-02-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-04T19:22:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT FLUCONAZOLE",
    "en_drug_common_name": "FLUCONAZOLE 100MG TAB",
    "fr_drug_brand_name": "ACT-FLUCONAZOLE 100MG TAB",
    "fr_drug_common_name": "FLUCONAZOLE 100MG TAB",
    "en_ingredients": "FLUCONAZOLE",
    "fr_ingredients": "Fluconazole",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183395,
    "drug": {
      "current_status": "MARKETED",
      "id": 16766,
      "drug_code": 77727,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255923,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02291908",
      "brand_name": "ACT ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325003"
    },
    "created_date": "2023-02-02T20:56:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02291908",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2023-07-10T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-12T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL 20MG  TAB",
    "fr_drug_brand_name": "ACT-ENALAPRIL 20MG  TAB",
    "fr_drug_common_name": "ENALAPRIL 20MG  TAB",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183398,
    "drug": {
      "current_status": "MARKETED",
      "id": 17654,
      "drug_code": 78712,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256204,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256203,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02301784",
      "brand_name": "TEVA-LISINOPRIL/HCTZ (TYPE Z)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0222417002"
    },
    "created_date": "2023-02-02T20:57:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02301784",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-16T19:47:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LISINOPRIL/HCTZ (TYPE Z)",
    "en_drug_common_name": "LISINOPRIL/HCTZ Z 20/25MG TAB",
    "fr_drug_brand_name": "TEVA-LISINOPRIL/HCTZ Z 20/25MG TAB",
    "fr_drug_common_name": "LISINOPRIL/HCTZ Z 20/25MG TAB",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLISINOPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nLisinopril",
    "drug_strength": "25MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183401,
    "drug": {
      "current_status": "MARKETED",
      "id": 20274,
      "drug_code": 81724,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257183,
          "ingredient": {
            "id": 674,
            "ingredient_code": 2395,
            "en_name": "LACTULOSE",
            "fr_name": "Lactulose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "667",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02331551",
      "brand_name": "TEVA-LACTULOSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113020001"
    },
    "created_date": "2023-02-02T20:57:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02331551",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A06AD",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LACTULOSE",
    "en_drug_common_name": "LACTULOSE 667MG/ML SACH 15ML",
    "fr_drug_brand_name": "TEVA-LACTULOSE 667MG/ML SACH 15ML",
    "fr_drug_common_name": "LACTULOSE 667MG/ML SACH 15ML",
    "en_ingredients": "LACTULOSE",
    "fr_ingredients": "Lactulose",
    "drug_strength": "667MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "20",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183404,
    "drug": {
      "current_status": "MARKETED",
      "id": 20912,
      "drug_code": 82909,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257397,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02343657",
      "brand_name": "TEVA-LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2023-02-02T20:59:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02343657",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2023-10-30T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-06T14:37:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LETROZOLE",
    "en_drug_common_name": "LETROZOLE 2.5MG TAB",
    "fr_drug_brand_name": "TEVA-LETROZOLE 2.5MG TAB",
    "fr_drug_common_name": "LETROZOLE 2.5MG TAB",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "pp 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183407,
    "drug": {
      "current_status": "MARKETED",
      "id": 21032,
      "drug_code": 83257,
      "updated_date": "2025-05-15T02:32:39-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257462,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257461,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347180",
      "brand_name": "TEVA-TRAMADOL/ACETAMINOPHEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250601001"
    },
    "created_date": "2023-02-02T21:00:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347180",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2023-06-20T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRAMADOL/ACETAMINOPHEN",
    "en_drug_common_name": "TRAMADOL/ACET 37.5/325MG TAB",
    "fr_drug_brand_name": "TEVA-TRAMADOL/ACET 37.5/325MG TAB",
    "fr_drug_common_name": "TRAMADOL/ACET 37.5/325MG TAB",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate de tramadol\r\nAcétaminophène",
    "drug_strength": "37.5MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183410,
    "drug": {
      "current_status": "MARKETED",
      "id": 22098,
      "drug_code": 84470,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257918,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359707",
      "brand_name": "TEVA-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2023-02-02T21:02:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359707",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE 20MG TAB",
    "fr_drug_brand_name": "TEVA-OLANZAPINE 20MG TAB",
    "fr_drug_common_name": "OLANZAPINE 20MG TAB",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183413,
    "drug": {
      "current_status": "MARKETED",
      "id": 22596,
      "drug_code": 85118,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258142,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366320",
      "brand_name": "TEVA-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2023-02-02T21:03:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366320",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2023-04-30T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN 16MG TABS",
    "fr_drug_brand_name": "TEVA-CANDESARTAN 16MG TABS",
    "fr_drug_common_name": "CANDESARTAN 16MG TABS",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183416,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27076,
      "drug_code": 89323,
      "updated_date": "2025-05-15T04:21:19-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8353271,
          "ingredient": {
            "id": 2818,
            "ingredient_code": 12019,
            "en_name": "EXEMESTANE",
            "fr_name": "Exémestane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408473",
      "brand_name": "TEVA-EXEMESTANE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141702001"
    },
    "created_date": "2023-02-02T21:04:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408473",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2023-03-20T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-EXEMESTANE",
    "en_drug_common_name": "EXEMESTANE 25MG TAB",
    "fr_drug_brand_name": "TEVA EXEMESTANE 25MG TAB",
    "fr_drug_common_name": "EXEMESTANE 25MG TAB",
    "en_ingredients": "EXEMESTANE",
    "fr_ingredients": "Exémestane",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183419,
    "drug": {
      "current_status": "MARKETED",
      "id": 30318,
      "drug_code": 92367,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261076,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439298",
      "brand_name": "TEVA-AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310006"
    },
    "created_date": "2023-02-02T21:05:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439298",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2023-08-30T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-09-07T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR 30MG CAPS",
    "fr_drug_brand_name": "ACT-AMPHETAMINE XR 30MG CAPS",
    "fr_drug_common_name": "AMPHETAMINE XR 30MG CAPS",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "AMPHETAMINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183422,
    "drug": {
      "current_status": "MARKETED",
      "id": 11566,
      "drug_code": 68490,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254312,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244513",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "100MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2023-02-02T21:08:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244513",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-09T15:40:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN 100MG CAPS",
    "fr_drug_brand_name": "TEVA-GABAPENTIN 100MG CAPS",
    "fr_drug_common_name": "GABAPENTIN 100MG CAPS",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100,500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183425,
    "drug": {
      "current_status": "MARKETED",
      "id": 21592,
      "drug_code": 83980,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257721,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354632",
      "brand_name": "TEVA-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2023-02-02T21:08:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354632",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2023-02-28T00:00:00-05:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "actual_end_date": "2023-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-09T15:42:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN 40MG TAB",
    "fr_drug_brand_name": "TEVA-ROSUVASTATIN 40MG TAB",
    "fr_drug_common_name": "ROSUVASTATIN 40MG TAB",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183474,
    "drug": {
      "current_status": "MARKETED",
      "id": 3300,
      "drug_code": 18355,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252304,
          "ingredient": {
            "id": 1396,
            "ingredient_code": 10040,
            "en_name": "OXYBUTYNIN CHLORIDE",
            "fr_name": "Chlorure d'oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02163543",
      "brand_name": "APO-OXYBUTYNIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80584",
      "number_of_ais": "1",
      "ai_group_no": "0114692001"
    },
    "created_date": "2023-02-02T21:44:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02163543",
    "company_name": "APOTEX INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2023-04-28T00:00:00-04:00",
    "actual_start_date": "2023-01-31T00:00:00-05:00",
    "actual_end_date": "2023-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-27T13:29:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OXYBUTYNIN",
    "en_drug_common_name": "OXYBUTYNIN",
    "fr_drug_brand_name": "APO-OXYBUTYNIN",
    "fr_drug_common_name": "OXYBUTYNIN",
    "en_ingredients": "OXYBUTYNIN CHLORIDE",
    "fr_ingredients": "Chlorure d'oxybutynine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183477,
    "drug": {
      "current_status": "MARKETED",
      "id": 16360,
      "drug_code": 77143,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255828,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285940",
      "brand_name": "APO-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2023-02-02T21:46:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285940",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2023-06-23T00:00:00-04:00",
    "actual_start_date": "2023-01-31T00:00:00-05:00",
    "actual_end_date": "2023-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-23T15:38:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "APO-LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183480,
    "drug": {
      "current_status": "MARKETED",
      "id": 16918,
      "drug_code": 77919,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255976,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293811",
      "brand_name": "APO-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666002"
    },
    "created_date": "2023-02-02T21:48:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293811",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-01-31T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T12:04:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "APO- LANSOPRAZOLE",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183483,
    "drug": {
      "current_status": "MARKETED",
      "id": 16812,
      "drug_code": 77772,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255940,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02292378",
      "brand_name": "APO-PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169001"
    },
    "created_date": "2023-02-02T21:49:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292378",
    "company_name": "APOTEX INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2023-04-14T00:00:00-04:00",
    "actual_start_date": "2023-01-31T00:00:00-05:00",
    "actual_end_date": "2023-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-14T16:24:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "APO-PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183486,
    "drug": {
      "current_status": "MARKETED",
      "id": 27342,
      "drug_code": 89592,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259889,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259888,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411318",
      "brand_name": "APO-AMLODIPINE-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555005"
    },
    "created_date": "2023-02-02T21:51:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411318",
    "company_name": "APOTEX INC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "estimated_end_date": "2023-02-28T00:00:00-05:00",
    "actual_start_date": "2023-01-31T00:00:00-05:00",
    "actual_end_date": "2023-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:08:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "en_drug_common_name": "AMLODIPINE/ATORVASTATIN",
    "fr_drug_brand_name": "APO-AMLODIPINE/ATORVASTATIN",
    "fr_drug_common_name": "AMLODIPINE/ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "AMLODIPINE/ATORVASTATIN",
    "drug_strength": "10MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183489,
    "drug": {
      "current_status": "MARKETED",
      "id": 12996,
      "drug_code": 72247,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254747,
          "ingredient": {
            "id": 1940,
            "ingredient_code": 10140,
            "en_name": "HYDROXYUREA",
            "fr_name": "Hydroxyurée"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247937",
      "brand_name": "APO-HYDROXYUREA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113432001"
    },
    "created_date": "2023-02-02T21:53:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247937",
    "company_name": "APOTEX INC",
    "atc_number": "L01XX",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2023-01-31T00:00:00-05:00",
    "actual_end_date": "2023-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-09T14:57:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDROXYUREA",
    "en_drug_common_name": "HYDROXYUREA",
    "fr_drug_brand_name": "APO-HYDROXYUREA",
    "fr_drug_common_name": "HYDROXYUREA",
    "en_ingredients": "HYDROXYUREA",
    "fr_ingredients": "Hydroxyurée",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE\r\nCAPSULE",
    "drug_dosage_form_fr": "Capsule\r\nCapsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183492,
    "drug": {
      "current_status": "MARKETED",
      "id": 16846,
      "drug_code": 77827,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255947,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292920",
      "brand_name": "APO-PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2023-02-02T21:54:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292920",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2023-02-22T00:00:00-05:00",
    "actual_start_date": "2023-01-31T00:00:00-05:00",
    "actual_end_date": "2023-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-23T12:09:33-05:00",
    "status": "resolved",
    "en_comments": "100 Btl available",
    "fr_comments": "100 btl disponible",
    "en_drug_brand_name": "APO-PANTOPRAZOLE",
    "en_drug_common_name": "PANTOPRAZOLE",
    "fr_drug_brand_name": "APO-PANTOPRAZOLE",
    "fr_drug_common_name": "PANTOPRAZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183495,
    "drug": {
      "current_status": "MARKETED",
      "id": 11540,
      "drug_code": 68362,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254303,
          "ingredient": {
            "id": 2134,
            "ingredient_code": 11118,
            "en_name": "CEFUROXIME",
            "fr_name": "Céfuroxime (Céfuroxime sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02244393",
      "brand_name": "APO-CEFUROXIME",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122448001"
    },
    "created_date": "2023-02-02T21:56:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244393",
    "company_name": "APOTEX INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2023-01-31T00:00:00-05:00",
    "actual_end_date": "2023-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-09T14:58:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CEFUROXIME",
    "en_drug_common_name": "CEFUROXIME",
    "fr_drug_brand_name": "APO-CEFUROXIME",
    "fr_drug_common_name": "CEFUROXIME",
    "en_ingredients": "CEFUROXIME",
    "fr_ingredients": "CEFUROXIME",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183506,
    "drug": {
      "current_status": "MARKETED",
      "id": 51739,
      "drug_code": 95086,
      "updated_date": "2025-05-15T02:35:49-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8262447,
          "ingredient": {
            "id": 2840,
            "ingredient_code": 12034,
            "en_name": "MOXIFLOXACIN",
            "fr_name": "Moxifloxacine (Chlorhydrate de moxifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02462974",
      "brand_name": "MOXIFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142242001"
    },
    "created_date": "2023-02-03T15:08:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02462974",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2023-05-17T00:00:00-04:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-05-18T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MOXIFLOXACIN",
    "en_drug_common_name": "MOXIFLOXACIN",
    "fr_drug_brand_name": "MOXIFLOXACIN",
    "fr_drug_common_name": "MOXIFLOXACIN",
    "en_ingredients": "MOXIFLOXACIN",
    "fr_ingredients": "MOXIFLOXACIN",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183509,
    "drug": {
      "current_status": "MARKETED",
      "id": 59167,
      "drug_code": 94949,
      "updated_date": "2025-12-03T00:33:20-05:00",
      "company": {
        "id": 7815,
        "created_date": "2018-05-03T02:30:12-04:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 17067,
        "mfr_code": "",
        "name": "AVIR PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262361,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02461722",
      "brand_name": "LEVOTHYROXINE SODIUM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107794010"
    },
    "created_date": "2023-02-03T15:16:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461722",
    "company_name": "AVIR PHARMA INC.",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2023-03-01T00:00:00-05:00",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_end_date": "2023-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-03-06T19:14:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVOTHYROXINE SODIUM FOR INJECTION",
    "en_drug_common_name": "Levothyroxine 500mcg",
    "fr_drug_brand_name": "Levothyroxine 500mcg",
    "fr_drug_common_name": "Levethyroxine 500mcg",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "500MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183517,
    "drug": {
      "current_status": "MARKETED",
      "id": 20816,
      "drug_code": 82676,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257365,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341220",
      "brand_name": "BUTRANS 20",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241008"
    },
    "created_date": "2023-02-03T15:51:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341220",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AE",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2023-02-03T00:00:00-05:00",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-02-09T21:31:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BUTRANS 20",
    "en_drug_common_name": "Buprenorphine Transdermal System",
    "fr_drug_brand_name": "BuTrans",
    "fr_drug_common_name": "Système transdermique de buprénorphine",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "20MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183519,
    "drug": {
      "current_status": "MARKETED",
      "id": 20816,
      "drug_code": 82676,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257365,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341220",
      "brand_name": "BUTRANS 20",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241008"
    },
    "created_date": "2023-02-03T15:51:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341220",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AE",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2023-02-03T00:00:00-05:00",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-02-17T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BUTRANS 20",
    "en_drug_common_name": "Buprenorphine Transdermal System",
    "fr_drug_brand_name": "BuTrans",
    "fr_drug_common_name": "Système transdermique de buprénorphine",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "20MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183524,
    "drug": {
      "current_status": "MARKETED",
      "id": 15598,
      "drug_code": 76284,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255593,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277190",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548011"
    },
    "created_date": "2023-02-03T15:55:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277190",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2023-02-02T00:00:00-05:00",
    "estimated_end_date": "2023-04-05T00:00:00-04:00",
    "actual_start_date": "2023-02-02T00:00:00-05:00",
    "actual_end_date": "2023-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-04-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183527,
    "drug": {
      "current_status": "MARKETED",
      "id": 15600,
      "drug_code": 76285,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255594,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277204",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548012"
    },
    "created_date": "2023-02-03T15:57:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277204",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2023-02-02T00:00:00-05:00",
    "estimated_end_date": "2023-04-05T00:00:00-04:00",
    "actual_start_date": "2023-02-02T00:00:00-05:00",
    "actual_end_date": "2023-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-04-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183530,
    "drug": {
      "current_status": "MARKETED",
      "id": 54630,
      "drug_code": 95928,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262888,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470306",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548015"
    },
    "created_date": "2023-02-03T15:59:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470306",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2023-02-02T00:00:00-05:00",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2023-02-02T00:00:00-05:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-02-16T15:09:48-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "35MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183533,
    "drug": {
      "current_status": "MARKETED",
      "id": 54638,
      "drug_code": 95932,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262892,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "85",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470349",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548013"
    },
    "created_date": "2023-02-03T16:00:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470349",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2023-02-02T00:00:00-05:00",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2023-02-02T00:00:00-05:00",
    "actual_end_date": "2023-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-02-17T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "85MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183589,
    "drug": {
      "current_status": "MARKETED",
      "id": 11932,
      "drug_code": 69763,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254426,
          "ingredient": {
            "id": 488,
            "ingredient_code": 1925,
            "en_name": "TRIMEBUTINE MALEATE",
            "fr_name": "Maléate de trimébutine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245663",
      "brand_name": "APO-TRIMEBUTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115865003"
    },
    "created_date": "2023-02-03T21:19:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245663",
    "company_name": "AA PHARMA INC",
    "atc_number": "A03AA",
    "atc_description": "DRUGS FOR FUNCTIONAL BOWEL DISORDERS",
    "estimated_end_date": "2023-04-14T00:00:00-04:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-17T19:50:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRIMEBUTINE",
    "en_drug_common_name": "Trimebutine",
    "fr_drug_brand_name": "Trimebutine",
    "fr_drug_common_name": "Trimebutine",
    "en_ingredients": "TRIMEBUTINE MALEATE",
    "fr_ingredients": "Maléate de trimébutine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183593,
    "drug": {
      "current_status": "MARKETED",
      "id": 7226,
      "drug_code": 4899,
      "updated_date": "2025-12-03T00:30:22-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250685,
          "ingredient": {
            "id": 2328,
            "ingredient_code": 6299,
            "en_name": "ACETAZOLAMIDE",
            "fr_name": "Acétazolamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00545015",
      "brand_name": "ACETAZOLAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59078",
      "number_of_ais": "1",
      "ai_group_no": "0107512001"
    },
    "created_date": "2023-02-03T21:23:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00545015",
    "company_name": "AA PHARMA INC",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2023-02-03T00:00:00-05:00",
    "estimated_end_date": "2023-04-14T00:00:00-04:00",
    "actual_end_date": "2023-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-05T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAZOLAMIDE",
    "en_drug_common_name": "Acetazolamide",
    "fr_drug_brand_name": "Acetazolamide",
    "fr_drug_common_name": "Acetazolamide",
    "en_ingredients": "ACETAZOLAMIDE",
    "fr_ingredients": "Acétazolamide",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183596,
    "drug": {
      "current_status": "MARKETED",
      "id": 5518,
      "drug_code": 3679,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250546,
          "ingredient": {
            "id": 176,
            "ingredient_code": 8452,
            "en_name": "TRIMETHOPRIM",
            "fr_name": "Triméthoprime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250545,
          "ingredient": {
            "id": 174,
            "ingredient_code": 8174,
            "en_name": "SULFAMETHOXAZOLE",
            "fr_name": "Sulfaméthoxazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00445282",
      "brand_name": "SULFATRIM DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55040",
      "number_of_ais": "2",
      "ai_group_no": "0208901003"
    },
    "created_date": "2023-02-03T21:25:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00445282",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01EE",
    "atc_description": "SULFONAMIDES AND TRIMETHOPRIM",
    "anticipated_start_date": "2023-02-24T00:00:00-05:00",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_end_date": "2023-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-30T20:18:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SULFATRIM DS",
    "en_drug_common_name": "Sulfatrim DS",
    "fr_drug_brand_name": "Sulfatrim DS",
    "fr_drug_common_name": "Sulfatrim DS",
    "en_ingredients": "TRIMETHOPRIM\r\nSULFAMETHOXAZOLE",
    "fr_ingredients": "Triméthoprime\r\nSulfaméthoxazole",
    "drug_strength": "160MG\r\n800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183599,
    "drug": {
      "current_status": "MARKETED",
      "id": 27294,
      "drug_code": 89541,
      "updated_date": "2025-05-15T02:34:01-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259864,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410745",
      "brand_name": "LORAZEPAM SUBLINGUAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110731003"
    },
    "created_date": "2023-02-03T21:26:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410745",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2023-02-28T00:00:00-05:00",
    "estimated_end_date": "2023-04-20T00:00:00-04:00",
    "actual_end_date": "2023-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-17T19:49:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LORAZEPAM SUBLINGUAL",
    "en_drug_common_name": "Lorazepam Sublingual",
    "fr_drug_brand_name": "Lorazepam Sublingual",
    "fr_drug_common_name": "Lorazepam Sublingual",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183620,
    "drug": {
      "current_status": "MARKETED",
      "id": 5596,
      "drug_code": 37198,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252894,
          "ingredient": {
            "id": 144,
            "ingredient_code": 182,
            "en_name": "DIPHENHYDRAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diphénhydramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02219336",
      "brand_name": "DIPHENIST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4674",
      "number_of_ais": "1",
      "ai_group_no": "0102639001"
    },
    "created_date": "2023-02-03T22:26:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02219336",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "R06AA",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "estimated_end_date": "2023-03-21T00:00:00-04:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-03-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-18T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DIPHENIST 50MG/ML",
    "en_drug_common_name": "Diphenhydramine Hydrochloride Injection USP",
    "fr_drug_brand_name": "Diphenist",
    "fr_drug_common_name": "Injection De Chlorhydrate de Diphénhydramine",
    "en_ingredients": "DIPHENHYDRAMINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diphénhydramine",
    "drug_strength": "50MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183623,
    "drug": {
      "current_status": "MARKETED",
      "id": 11174,
      "drug_code": 67481,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254200,
          "ingredient": {
            "id": 154,
            "ingredient_code": 3776,
            "en_name": "METOCLOPRAMIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de métoclopramide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243563",
      "brand_name": "METOCLOPRAMIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109394003"
    },
    "created_date": "2023-02-03T22:31:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243563",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "A03FA",
    "atc_description": "PROPULSIVES",
    "actual_start_date": "2023-02-17T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METOCLOPRAMIDE OMEGA",
    "en_drug_common_name": "Metoclopramide Hydrochloride Injection USP",
    "fr_drug_brand_name": "Metoclopramide Omega",
    "fr_drug_common_name": "Injection De Chlorhydrate de métoclopramide",
    "en_ingredients": "METOCLOPRAMIDE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de métoclopramide",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 2 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183628,
    "drug": {
      "current_status": "MARKETED",
      "id": 25322,
      "drug_code": 87801,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8259177,
          "ingredient": {
            "id": 1368,
            "ingredient_code": 1988,
            "en_name": "TRANEXAMIC ACID",
            "fr_name": "Acide tranexamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02392763",
      "brand_name": "TRANEXAMIC ACID INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114760002"
    },
    "created_date": "2023-02-03T22:38:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392763",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B02AA",
    "atc_description": "ANTIFIBRINOLYTICS",
    "actual_start_date": "2023-02-17T00:00:00-05:00",
    "actual_end_date": "2023-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-17T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRANEXAMIC ACID INJECTION",
    "en_drug_common_name": "Tranexamic Acid Injection",
    "fr_drug_brand_name": "Acide Tranexamique Injectable",
    "fr_drug_common_name": "Acide Tranexamique Injectable",
    "en_ingredients": "TRANEXAMIC ACID",
    "fr_ingredients": "Acide tranexamique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 10mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183651,
    "drug": {
      "current_status": "MARKETED",
      "id": 100919,
      "drug_code": 99365,
      "updated_date": "2025-12-03T00:35:36-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265542,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02504219",
      "brand_name": "JAMP ATORVASTATIN TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2023-02-06T13:55:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02504219",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-12T03:40:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP ATORVASTATIN CALCIUM",
    "en_drug_common_name": "Atorvastatin calcium",
    "fr_drug_brand_name": "JAMP Atorvastatin Calcium",
    "fr_drug_common_name": "Atorvastatine calcique",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATINE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3x10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183655,
    "drug": {
      "current_status": "DORMANT",
      "id": 66083,
      "drug_code": 94459,
      "updated_date": "2025-12-03T02:32:40-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369414,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8369413,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02457539",
      "brand_name": "JAMP DORZOLAMIDE-TIMOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2023-02-06T14:18:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457539",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-20T15:50:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP DORZOLAMIDE-TIMOLOL",
    "en_drug_common_name": "Dorzolamide and timolol",
    "fr_drug_brand_name": "JAMP DORZOLAMIDE-TIMOLOL",
    "fr_drug_common_name": "Dorzolamide et timolol",
    "en_ingredients": "TIMOLOL\r\nDORZOLAMIDE",
    "fr_ingredients": "TIMOLOL DORZOLAMIDE",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183668,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25800,
      "drug_code": 88177,
      "updated_date": "2025-05-15T04:20:41-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352399,
          "ingredient": {
            "id": 3452,
            "ingredient_code": 20195,
            "en_name": "ETRAVIRINE",
            "fr_name": "Étravirine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396750",
      "brand_name": "INTELENCE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152450003"
    },
    "created_date": "2023-02-06T14:59:26-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02396750",
    "company_name": "JANSSEN INC",
    "atc_number": "J05AG",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2023-08-08T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-08-04T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-08-09T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "INTELENCE",
    "en_drug_common_name": "INTELENCE",
    "fr_drug_brand_name": "INTELENCE",
    "fr_drug_common_name": "INTELENCE",
    "en_ingredients": "ETRAVIRINE",
    "fr_ingredients": "Étravirine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 x 120",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183671,
    "drug": {
      "current_status": "DORMANT",
      "id": 100181,
      "drug_code": 98501,
      "updated_date": "2020-04-03T06:54:28-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369699,
          "ingredient": {
            "id": 3134,
            "ingredient_code": 12429,
            "en_name": "IMATINIB",
            "fr_name": "Imatinib (Mésylate d'imatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02495066",
      "brand_name": "JAMP IMATINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145503002"
    },
    "created_date": "2023-02-06T17:59:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02495066",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "L01EA",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2024-05-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-05-04T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Bottle available",
    "fr_comments": "Bouteille disponible",
    "en_drug_brand_name": "JAMP IMATINIB",
    "en_drug_common_name": "Imatinib mesylate",
    "fr_drug_brand_name": "JAMP Imatinib",
    "fr_drug_common_name": "Mésylate d'imatinib",
    "en_ingredients": "IMATINIB",
    "fr_ingredients": "IMATINIB",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "12x10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183674,
    "drug": {
      "current_status": "MARKETED",
      "id": 50706,
      "drug_code": 94932,
      "updated_date": "2025-05-15T02:35:45-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262356,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461668",
      "brand_name": "JAMP OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496003"
    },
    "created_date": "2023-02-06T18:08:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461668",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-12T03:35:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP OLMESARTAN",
    "en_drug_common_name": "Olmesartan medoxomil",
    "fr_drug_brand_name": "JAMP Olmesartan",
    "fr_drug_common_name": "Olmésartan médoxomil",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "OLMESARTAN MEDOXOMIL",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183677,
    "drug": {
      "current_status": "MARKETED",
      "id": 20232,
      "drug_code": 81671,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257170,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330970",
      "brand_name": "JAMP-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2023-02-06T18:13:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330970",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2023-04-10T00:00:00-04:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-04-03T17:25:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin Sodium",
    "fr_drug_brand_name": "JAMP-PRAVASTATIN",
    "fr_drug_common_name": "Pravastatine sodique",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183684,
    "drug": {
      "current_status": "MARKETED",
      "id": 23260,
      "drug_code": 85829,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258406,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.005",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8258405,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02373130",
      "brand_name": "XYLOCAINE 2% WITH EPINEPHRINE 1:200000",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0201284006"
    },
    "created_date": "2023-02-06T18:42:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02373130",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2023-08-15T00:00:00-04:00",
    "estimated_end_date": "2024-01-01T00:00:00-05:00",
    "actual_start_date": "2023-08-04T00:00:00-04:00",
    "actual_end_date": "2024-01-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-04T16:13:44-05:00",
    "status": "resolved",
    "en_comments": "VR44551CA1\tXYLOCAIN AD20MG:5MCG/ML MDV10X20ML CA AS",
    "en_drug_brand_name": "XYLOCAINE 2% WITH EPINEPHRINE 1:200000",
    "en_drug_common_name": "lidocaine HCI 2% w/epin. 1:200M 10x20mL MD Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial",
    "en_ingredients": "EPINEPHRINE\r\nLIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Épinéphrine\r\nChlorhydrate de lidocaïne",
    "drug_strength": "0.005MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183689,
    "drug": {
      "current_status": "MARKETED",
      "id": 8440,
      "drug_code": 589,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250161,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250160,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00001791",
      "brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:100000",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23890",
      "number_of_ais": "2",
      "ai_group_no": "0201284001"
    },
    "created_date": "2023-02-06T18:46:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00001791",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2023-07-15T00:00:00-04:00",
    "estimated_end_date": "2023-09-30T00:00:00-04:00",
    "actual_end_date": "2023-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-07T19:55:11-05:00",
    "status": "avoided_shortage",
    "en_comments": "VR44553CA1\tXYLOCAIN AD 10MG:10MCG VIL 10X20ML",
    "en_drug_brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:100000",
    "en_drug_common_name": "Xylocaine® 1% w/epin. 1:100M 10x20mL MD Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial",
    "en_ingredients": "EPINEPHRINE\r\nLIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Épinéphrine\r\nChlorhydrate de lidocaïne",
    "drug_strength": "0.01MG\r\n10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183697,
    "drug": {
      "current_status": "MARKETED",
      "id": 17698,
      "drug_code": 78773,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256218,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02302411",
      "brand_name": "XYLOCAINE 1%",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2023-02-06T18:51:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302411",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2023-10-01T00:00:00-04:00",
    "estimated_end_date": "2023-10-31T00:00:00-04:00",
    "actual_end_date": "2023-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-05-02T19:45:04-04:00",
    "status": "avoided_shortage",
    "en_comments": "VR44571CA1\tXYLOCAINE 10MG/ML LIQ MDV 10X20ML CA ASP",
    "en_drug_brand_name": "XYLOCAINE 1%",
    "en_drug_common_name": "Xylocaine® 1% Plain 10x20mL MD Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "Xylocaine® 1% Plain 10x20mL MD Vial",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183701,
    "drug": {
      "current_status": "MARKETED",
      "id": 9304,
      "drug_code": 62447,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253633,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02238998",
      "brand_name": "RHO-NITRO PUMPSPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103615009"
    },
    "created_date": "2023-02-06T18:56:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238998",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "estimated_end_date": "2023-05-19T00:00:00-04:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-05-03T18:16:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RHO-NITRO PUMPSPRAY",
    "en_drug_common_name": "RHO-NITRO",
    "fr_drug_brand_name": "RHO-NITRO POMPE",
    "fr_drug_common_name": "RHO-NITRO",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "METERED-DOSE PUMP",
    "drug_dosage_form_fr": "Pompe à dose mesurée",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "200DOS LSP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183705,
    "drug": {
      "current_status": "MARKETED",
      "id": 98613,
      "drug_code": 92727,
      "updated_date": "2024-03-09T03:04:10-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261274,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442817",
      "brand_name": "JAMP TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115713002"
    },
    "created_date": "2023-02-06T20:28:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442817",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-09-30T00:00:00-04:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-08-09T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP TRAZODONE",
    "en_drug_common_name": "Trazodone hydrochloride",
    "fr_drug_brand_name": "JAMP TRAZODONE",
    "fr_drug_common_name": "Chlorhydrate de trazodone",
    "fr_ingredients": "Trazodone",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183708,
    "drug": {
      "current_status": "MARKETED",
      "id": 101983,
      "drug_code": 100588,
      "updated_date": "2021-07-08T05:10:07-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266334,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02516535",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294002"
    },
    "created_date": "2023-02-06T20:46:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02516535",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2025-02-15T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2025-03-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-18T14:56:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "Venlafaxine Hydrochloride",
    "fr_drug_brand_name": "Venlafaxine XR",
    "fr_drug_common_name": "Chlorhydrate de venlafaxine",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine",
    "drug_strength": "37.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183710,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 66133,
      "drug_code": 97570,
      "updated_date": "2025-05-15T04:26:15-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8358196,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "50",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02485451",
      "brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830008"
    },
    "created_date": "2023-02-06T20:46:46-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02485451",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2023-04-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-04-02T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "en_drug_common_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE (300mg/50mL)",
    "fr_drug_brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE (300mg/50mL)",
    "fr_drug_common_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE (300mg/50mL)",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "Clindamycin",
    "drug_strength": "300MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50ml",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183714,
    "drug": {
      "current_status": "MARKETED",
      "id": 66135,
      "drug_code": 97571,
      "updated_date": "2025-05-15T02:37:29-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263887,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "50",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02485478",
      "brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830009"
    },
    "created_date": "2023-02-06T20:48:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485478",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2023-06-10T00:00:00-04:00",
    "estimated_end_date": "2023-10-31T00:00:00-04:00",
    "actual_start_date": "2023-06-10T00:00:00-04:00",
    "actual_end_date": "2023-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2023-11-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "en_drug_common_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "fr_drug_brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "fr_drug_common_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "Clindamycin",
    "drug_strength": "600MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183717,
    "drug": {
      "current_status": "MARKETED",
      "id": 66456,
      "drug_code": 97572,
      "updated_date": "2025-05-15T02:37:29-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263888,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "50",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02485486",
      "brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830010"
    },
    "created_date": "2023-02-06T20:50:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485486",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2023-04-27T00:00:00-04:00",
    "estimated_end_date": "2023-10-31T00:00:00-04:00",
    "actual_start_date": "2023-04-27T00:00:00-04:00",
    "actual_end_date": "2023-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2023-11-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "en_drug_common_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "fr_drug_brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "fr_drug_common_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "Clindamycin",
    "drug_strength": "900MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183720,
    "drug": {
      "current_status": "MARKETED",
      "id": 98614,
      "drug_code": 92729,
      "updated_date": "2024-03-09T03:04:10-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261275,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442825",
      "brand_name": "JAMP TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115713003"
    },
    "created_date": "2023-02-06T20:52:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442825",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-09-30T00:00:00-04:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-08-09T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP TRAZODONE",
    "en_drug_common_name": "Trazodone hydrochloride",
    "fr_drug_brand_name": "JAMP Trazodone",
    "fr_drug_common_name": "Chlorhydrate de trazodone",
    "fr_ingredients": "Trazodone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183725,
    "drug": {
      "current_status": "MARKETED",
      "id": 98612,
      "drug_code": 92726,
      "updated_date": "2024-03-09T03:04:10-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261273,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442809",
      "brand_name": "JAMP TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115713001"
    },
    "created_date": "2023-02-06T21:23:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442809",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-09-30T00:00:00-04:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-08-09T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP TRAZODONE",
    "en_drug_common_name": "Trazodone hydrochloride",
    "fr_drug_brand_name": "JAMP Trazodone",
    "fr_drug_common_name": "Chlorhydrate de trazodone",
    "fr_ingredients": "Trazodone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183728,
    "drug": {
      "current_status": "MARKETED",
      "id": 101983,
      "drug_code": 100588,
      "updated_date": "2021-07-08T05:10:07-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266334,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02516535",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294002"
    },
    "created_date": "2023-02-06T21:30:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02516535",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2025-02-15T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2025-03-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-18T14:57:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "Venlafaxine Hydrochloride",
    "fr_drug_brand_name": "Venlafaxine XR",
    "fr_drug_common_name": "Chlorhydrate de venlafaxine",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine",
    "drug_strength": "37.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183733,
    "drug": {
      "current_status": "MARKETED",
      "id": 101984,
      "drug_code": 100589,
      "updated_date": "2021-07-08T05:10:08-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266335,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02516543",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2023-02-06T21:34:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02516543",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-08-20T00:00:00-04:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2024-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-08-29T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "Venlafaxine Hydrochloride",
    "fr_drug_brand_name": "Venlafaxine XR",
    "fr_drug_common_name": "Chlorhydrate de venlafaxine",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183736,
    "drug": {
      "current_status": "MARKETED",
      "id": 101984,
      "drug_code": 100589,
      "updated_date": "2021-07-08T05:10:08-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266335,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02516543",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2023-02-06T21:40:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02516543",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-12-13T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2024-12-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-03T22:49:31-05:00",
    "status": "resolved",
    "en_comments": "Bottle 500 available",
    "fr_comments": "Bouteille 500 disponible",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "Venlafaxine Hydrochloride",
    "fr_drug_brand_name": "Venlafaxine XR",
    "fr_drug_common_name": "Chlorhydrate de venlafaxine",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183741,
    "drug": {
      "current_status": "DORMANT",
      "id": 98210,
      "drug_code": 90796,
      "updated_date": "2020-12-09T00:55:26-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369091,
          "ingredient": {
            "id": 2674,
            "ingredient_code": 1400,
            "en_name": "AMIODARONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiodarone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02423227",
      "brand_name": "AMIODARONE HYDROCHLORIDE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118593002"
    },
    "created_date": "2023-02-06T22:09:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423227",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C01BD",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "anticipated_start_date": "2023-05-15T00:00:00-04:00",
    "estimated_end_date": "2023-06-15T00:00:00-04:00",
    "actual_end_date": "2023-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-03-12T03:32:58-04:00",
    "status": "avoided_shortage",
    "en_comments": "Under allocation",
    "fr_comments": "Sous allocation",
    "en_drug_brand_name": "AMIODARONE HYDROCHLORIDE FOR INJECTION",
    "en_drug_common_name": "Amiodarone Hydrochloride",
    "fr_drug_brand_name": "CHLORHYDRATE D’AMIODARONE POUR INJECTION",
    "fr_drug_common_name": "Chlorhydrate d’amiodarone",
    "en_ingredients": "AMIODARONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amiodarone",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 3 mL vials",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183744,
    "drug": {
      "current_status": "MARKETED",
      "id": 25858,
      "drug_code": 88227,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259330,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02397307",
      "brand_name": "JAMP PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541001"
    },
    "created_date": "2023-02-06T22:16:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02397307",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2023-12-15T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2025-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-17T01:33:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP PIOGLITAZONE",
    "en_drug_common_name": "Pioglitazone hydrochloride",
    "fr_drug_brand_name": "JAMP Pioglitazone",
    "fr_drug_common_name": "Chlorhydrate de pioglitazone",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "Pioglitazone",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183756,
    "drug": {
      "current_status": "MARKETED",
      "id": 29474,
      "drug_code": 91497,
      "updated_date": "2025-05-15T02:34:31-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260696,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02430568",
      "brand_name": "CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243002"
    },
    "created_date": "2023-02-06T22:31:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02430568",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-04-10T00:00:00-04:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-03T17:19:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CITALOPRAM",
    "en_drug_common_name": "Citalopram hydrobromide",
    "fr_drug_brand_name": "Citalopram",
    "fr_drug_common_name": "Bromhydrate de citalopram",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "Citalopram",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "3x10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183760,
    "drug": {
      "current_status": "DORMANT",
      "id": 24436,
      "drug_code": 87070,
      "updated_date": "2025-05-15T06:55:45-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368775,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385031",
      "brand_name": "JAMP-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2023-02-06T22:47:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385031",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2024-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-04-17T23:22:35-04:00",
    "status": "resolved",
    "en_comments": "New DIN available",
    "fr_comments": "Nouveau DIN disponible",
    "en_drug_brand_name": "JAMP-ALENDRONATE",
    "en_drug_common_name": "Alendronate sodium trihydrate",
    "fr_drug_brand_name": "JAMP-Alendronate",
    "fr_drug_common_name": "Alendronate sodique trihydraté",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ACIDE ALENDRONIQUE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183765,
    "drug": {
      "current_status": "MARKETED",
      "id": 29846,
      "drug_code": 91887,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8260821,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434547",
      "brand_name": "MYLAN-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282002"
    },
    "created_date": "2023-02-06T22:53:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434547",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "anticipated_start_date": "2023-03-08T00:00:00-05:00",
    "estimated_end_date": "2023-04-25T00:00:00-04:00",
    "actual_start_date": "2023-03-16T00:00:00-04:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-01T18:12:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-CINACALCET",
    "en_drug_common_name": "CINACALCET",
    "fr_drug_brand_name": "MYLAN-CINACALCET",
    "fr_drug_common_name": "CINACALCET",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "CINACALCET",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183768,
    "drug": {
      "current_status": "MARKETED",
      "id": 29848,
      "drug_code": 91888,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8260822,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434555",
      "brand_name": "MYLAN-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282003"
    },
    "created_date": "2023-02-06T22:54:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434555",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "anticipated_start_date": "2023-04-05T00:00:00-04:00",
    "estimated_end_date": "2023-05-08T00:00:00-04:00",
    "actual_start_date": "2023-04-05T00:00:00-04:00",
    "actual_end_date": "2023-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-08T17:10:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-CINACALCET",
    "en_drug_common_name": "CINACALCET",
    "fr_drug_brand_name": "MYLAN-CINACALCET",
    "fr_drug_common_name": "MYLAN-CINACALCET",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "CINACALCET",
    "drug_strength": "90MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183775,
    "drug": {
      "current_status": "DORMANT",
      "id": 22860,
      "drug_code": 85385,
      "updated_date": "2025-05-15T06:55:43-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368651,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02368889",
      "brand_name": "JAMP-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131001"
    },
    "created_date": "2023-02-06T22:59:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02368889",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2024-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-04-17T23:28:00-04:00",
    "status": "resolved",
    "en_comments": "New DIN available",
    "fr_comments": "Nouveau DIN disponible",
    "en_drug_brand_name": "JAMP-PAROXETINE",
    "en_drug_common_name": "Paroxetine hydrochloride",
    "fr_drug_brand_name": "JAMP-Paroxetine",
    "fr_drug_common_name": "Chlorhydrate de paroxétine",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "Paroxétine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183778,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25166,
      "drug_code": 87662,
      "updated_date": "2025-05-15T04:20:25-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351915,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391279",
      "brand_name": "JAMP-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2023-02-06T23:04:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391279",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2024-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-04-17T23:28:40-04:00",
    "status": "resolved",
    "en_comments": "New DIN available",
    "fr_comments": "Nouveau DIN disponible",
    "en_drug_brand_name": "JAMP-ROSUVASTATIN",
    "en_drug_common_name": "Rosuvastatin calcium",
    "fr_drug_brand_name": "JAMP-ROSUVASTATIN",
    "fr_drug_common_name": "Rosuvastatine calcique",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "Rosuvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183781,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25166,
      "drug_code": 87662,
      "updated_date": "2025-05-15T04:20:25-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351915,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391279",
      "brand_name": "JAMP-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2023-02-06T23:09:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391279",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2024-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-04-17T23:29:29-04:00",
    "status": "resolved",
    "en_comments": "New DIN available",
    "fr_comments": "Nouveau DIN disponible",
    "en_drug_brand_name": "JAMP-ROSUVASTATIN",
    "en_drug_common_name": "Rosuvastatin calcium",
    "fr_drug_brand_name": "JAMP-ROSUVASTATIN",
    "fr_drug_common_name": "Rosuvastatine calcique",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "Rosuvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183828,
    "drug": {
      "current_status": "MARKETED",
      "id": 9762,
      "drug_code": 63789,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 272,
        "created_date": "2017-03-09T13:22:39-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12428,
        "mfr_code": "",
        "name": "SANOFI PASTEUR LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "Customer Service/Service à la clientèle: 1-800-268-4171\r\nVaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146"
      },
      "drug_ingredients": [
        {
          "id": 8253750,
          "ingredient": {
            "id": 2398,
            "ingredient_code": 7935,
            "en_name": "TETANUS TOXOID",
            "fr_name": "Anatoxine tétanique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "LF",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253749,
          "ingredient": {
            "id": 2688,
            "ingredient_code": 20594,
            "en_name": "FIMBRIAE TYPES 2 AND 3",
            "fr_name": "Fimbriae Types 2 et 3 (FIM)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253748,
          "ingredient": {
            "id": 2390,
            "ingredient_code": 17,
            "en_name": "PERTACTIN",
            "fr_name": "Pertactine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253747,
          "ingredient": {
            "id": 2394,
            "ingredient_code": 19,
            "en_name": "FILAMENTOUS HAEMAGGLUTININ",
            "fr_name": "Hémagglutinine filamenteuse"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253746,
          "ingredient": {
            "id": 2400,
            "ingredient_code": 7941,
            "en_name": "DIPHTHERIA TOXOID",
            "fr_name": "Anatoxine diphtérique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "LF",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253745,
          "ingredient": {
            "id": 2396,
            "ingredient_code": 20,
            "en_name": "PERTUSSIS TOXOID",
            "fr_name": "Anatoxine coquelucheuse"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240255",
      "brand_name": "ADACEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "6",
      "ai_group_no": "0652741001"
    },
    "created_date": "2023-02-07T15:25:14-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240255",
    "company_name": "SANOFI PASTEUR LIMITED",
    "atc_number": "J07AJ",
    "atc_description": "BACTERIAL VACCINES",
    "anticipated_discontinuation_date": "2023-03-10T00:00:00-05:00",
    "decision_reversal": true,
    "en_discontinuation_comments": "The format 5x1 remains available.",
    "fr_discontinuation_comments": "Le format 5x1 reste disponible.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-02-14T18:31:56-05:00",
    "status": "reversed",
    "en_drug_brand_name": "ADACEL",
    "en_drug_common_name": "Adacel",
    "fr_drug_brand_name": "ADACEL",
    "fr_drug_common_name": "Adacel",
    "en_ingredients": "FIMBRIAE TYPES 2 AND 3\r\nTETANUS TOXOID\r\nDIPHTHERIA TOXOID\r\nPERTACTIN\r\nPERTUSSIS TOXOID\r\nFILAMENTOUS HAEMAGGLUTININ",
    "fr_ingredients": "Anatoxine tétanique\r\nAnatoxine diphtérique\r\nPertactine\r\nAnatoxine coquelucheuse\r\nHémagglutinine filamenteuse",
    "drug_strength": "5MCG\r\n5LF\r\n2LF\r\n3MCG\r\n2.5MCG\r\n5MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1x1",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183864,
    "drug": {
      "current_status": "MARKETED",
      "id": 9092,
      "drug_code": 61820,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253575,
          "ingredient": {
            "id": 822,
            "ingredient_code": 8029,
            "en_name": "METHOTRIMEPRAZINE",
            "fr_name": "Méthotriméprazine (Maléate de méthotriméprazine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238403",
      "brand_name": "METHOPRAZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134080005"
    },
    "created_date": "2023-02-08T16:27:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238403",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05AA",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2023-03-15T00:00:00-04:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T13:54:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHOPRAZINE",
    "en_drug_common_name": "Methoprazine",
    "fr_drug_brand_name": "Methoprazine",
    "fr_drug_common_name": "Methoprazine",
    "en_ingredients": "METHOTRIMEPRAZINE",
    "fr_ingredients": "MALÉATE DE MÉTHOTRIMÉPRAZINE",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183867,
    "drug": {
      "current_status": "DORMANT",
      "id": 12806,
      "drug_code": 71828,
      "updated_date": "2025-05-15T06:55:30-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367619,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247573",
      "brand_name": "PMS-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752001"
    },
    "created_date": "2023-02-08T16:40:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247573",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2023-05-23T00:00:00-04:00",
    "actual_start_date": "2023-01-25T00:00:00-05:00",
    "actual_end_date": "2023-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-11T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Sku is discontinued",
    "fr_comments": "Sku est discontinué",
    "en_drug_brand_name": "PMS-CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "pms-CLARITHROMYCIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183870,
    "drug": {
      "current_status": "MARKETED",
      "id": 31276,
      "drug_code": 9349,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251147,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00728187",
      "brand_name": "PMS-LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68358",
      "number_of_ais": "1",
      "ai_group_no": "0110731003"
    },
    "created_date": "2023-02-08T16:43:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00728187",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2023-03-22T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-03-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-21T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LORAZEPAM",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "pms-LORAZEPAM",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183891,
    "drug": {
      "current_status": "MARKETED",
      "id": 2834,
      "drug_code": 16852,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252165,
          "ingredient": {
            "id": 116,
            "ingredient_code": 9880,
            "en_name": "METRONIDAZOLE",
            "fr_name": "Métronidazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.75",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02125226",
      "brand_name": "NIDAGEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78883",
      "number_of_ais": "1",
      "ai_group_no": "0102572005"
    },
    "created_date": "2023-02-08T19:52:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02125226",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "G01AF",
    "atc_description": "ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",
    "anticipated_start_date": "2023-03-31T00:00:00-04:00",
    "estimated_end_date": "2023-06-30T00:00:00-04:00",
    "actual_start_date": "2023-03-20T00:00:00-04:00",
    "actual_end_date": "2023-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2023-06-29T15:23:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NIDAGEL",
    "en_drug_common_name": "NIDAGEL",
    "fr_drug_brand_name": "NIDAGEL",
    "fr_drug_common_name": "NIDAGEL",
    "en_ingredients": "METRONIDAZOLE",
    "fr_ingredients": "Métronidazole",
    "drug_strength": "0.75%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "VAGINAL\r\nVAGINAL",
    "drug_route_fr": "Vaginale\r\nVaginale",
    "drug_package_quantity": "70g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183894,
    "drug": {
      "current_status": "MARKETED",
      "id": 26574,
      "drug_code": 88879,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259597,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8259596,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02404044",
      "brand_name": "XERESE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0254151001"
    },
    "created_date": "2023-02-08T19:55:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02404044",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D06BB",
    "atc_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
    "anticipated_start_date": "2023-04-21T00:00:00-04:00",
    "estimated_end_date": "2023-06-13T00:00:00-04:00",
    "actual_end_date": "2023-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2023-04-11T18:21:42-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "XERESE",
    "en_drug_common_name": "XERESE",
    "fr_drug_brand_name": "XERESE",
    "fr_drug_common_name": "XERESE",
    "en_ingredients": "HYDROCORTISONE\r\nACYCLOVIR",
    "fr_ingredients": "Hydrocortisone\r\nAcyclovir",
    "drug_strength": "1%\r\n5%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "5g",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 183909,
    "drug": {
      "current_status": "MARKETED",
      "id": 29458,
      "drug_code": 91483,
      "updated_date": "2025-05-15T02:34:31-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8260691,
          "ingredient": {
            "id": 4002,
            "ingredient_code": 22511,
            "en_name": "ANTIHEMOPHILIC FACTOR",
            "fr_name": "Facteur Antihémophilique (Recombiné BDD), Protéine Hybride FC"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02430347",
      "brand_name": "ELOCTATE",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL (POWDER), PRE-FILLED SYRINGE (DILUENT)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0155970006"
    },
    "created_date": "2023-02-08T21:40:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02430347",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B02BD",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "estimated_end_date": "2023-03-15T00:00:00-04:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-07T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ELOCTATE",
    "en_drug_common_name": "ELOCTATE 2000",
    "fr_drug_brand_name": "ELOCTATE",
    "fr_drug_common_name": "ELOCTATE 2000",
    "en_ingredients": "ANTIHEMOPHILIC FACTOR",
    "drug_strength": "2000UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2000 IU/vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184072,
    "drug": {
      "current_status": "DORMANT",
      "id": 4154,
      "drug_code": 20011,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367037,
          "ingredient": {
            "id": 1618,
            "ingredient_code": 1890,
            "en_name": "BUSPIRONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de buspirone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02211076",
      "brand_name": "APO-BUSPIRONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82310",
      "number_of_ais": "1",
      "ai_group_no": "0116263001"
    },
    "created_date": "2023-02-09T16:02:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02211076",
    "company_name": "APOTEX INC",
    "atc_number": "N05BE",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2023-05-19T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-12T12:50:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BUSPIRONE",
    "en_drug_common_name": "BUSPIRONE",
    "fr_drug_brand_name": "APO-BUSPIRONE",
    "fr_drug_common_name": "BUSPIRONE",
    "en_ingredients": "BUSPIRONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de buspirone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184077,
    "drug": {
      "current_status": "MARKETED",
      "id": 9920,
      "drug_code": 64159,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253788,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "TAB",
          "base": false
        }
      ],
      "din": "02240588",
      "brand_name": "APO-DOXAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131431001"
    },
    "created_date": "2023-02-09T16:04:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240588",
    "company_name": "APOTEX INC",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-03-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-23T10:26:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOXAZOSIN",
    "en_drug_common_name": "DOXAZOSIN",
    "fr_drug_brand_name": "APO-DOXAZOSIN",
    "fr_drug_common_name": "DOXAZOSIN",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "DOXAZOSIN",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184080,
    "drug": {
      "current_status": "MARKETED",
      "id": 12536,
      "drug_code": 71248,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254606,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247014",
      "brand_name": "APO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2023-02-09T16:06:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247014",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-16T23:06:59-05:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "fr_comments": "100 BTL disponible",
    "en_drug_brand_name": "APO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "APO-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184083,
    "drug": {
      "current_status": "MARKETED",
      "id": 15968,
      "drug_code": 76748,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255703,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281821",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2023-02-09T16:08:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281821",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2023-06-02T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-02T15:17:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184086,
    "drug": {
      "current_status": "MARKETED",
      "id": 31558,
      "drug_code": 93875,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261800,
          "ingredient": {
            "id": 610,
            "ingredient_code": 1249,
            "en_name": "FELODIPINE",
            "fr_name": "Félodipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452367",
      "brand_name": "APO-FELODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121733003"
    },
    "created_date": "2023-02-09T16:09:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452367",
    "company_name": "APOTEX INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:11:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FELODIPINE",
    "en_drug_common_name": "FELODIPINE",
    "fr_drug_brand_name": "APO-FELODIPINE",
    "fr_drug_common_name": "FELODIPINE",
    "en_ingredients": "FELODIPINE",
    "fr_ingredients": "Félodipine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184089,
    "drug": {
      "current_status": "MARKETED",
      "id": 16920,
      "drug_code": 77920,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255977,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293838",
      "brand_name": "APO-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666001"
    },
    "created_date": "2023-02-09T16:11:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293838",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T12:03:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "APO-LANSOPRAZOLE",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184092,
    "drug": {
      "current_status": "MARKETED",
      "id": 96964,
      "drug_code": 78291,
      "updated_date": "2020-04-03T06:51:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256084,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256083,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02297574",
      "brand_name": "APO-PERINDOPRIL-INDAPAMIDE",
      "brand_name_fr": "APO-PERINDOPRIL-INDAPAMIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248401001"
    },
    "created_date": "2023-02-09T16:12:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02297574",
    "company_name": "APOTEX INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "hc_updated_date": "2023-06-23T18:43:10-04:00",
    "estimated_end_date": "2023-09-22T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-09-22T16:42:11-04:00",
    "status": "resolved",
    "fr_comments": "100 BTL disponible",
    "en_drug_brand_name": "APO-PERINDOPRIL-INDAPAMIDE",
    "en_drug_common_name": "PERINDOPRIL-INDAPAMIDE",
    "fr_drug_brand_name": "APO-PERINDOPRIL-INDAPAMIDE",
    "fr_drug_common_name": "PERINDOPRIL-INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE\r\nPERINDOPRIL ERBUMINE",
    "fr_ingredients": "Indapamide\r\nPérindopril erbumine",
    "drug_strength": "1.25MG\r\n4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184097,
    "drug": {
      "current_status": "MARKETED",
      "id": 20358,
      "drug_code": 81866,
      "updated_date": "2025-12-03T00:31:29-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257208,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02333015",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2023-02-09T16:14:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02333015",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2023-06-02T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-02T15:17:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184100,
    "drug": {
      "current_status": "MARKETED",
      "id": 53455,
      "drug_code": 94808,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262286,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02460653",
      "brand_name": "APO-METFORMIN ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773003"
    },
    "created_date": "2023-02-09T16:16:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460653",
    "company_name": "APOTEX INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2023-02-24T00:00:00-05:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-23T12:06:55-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METFORMIN ER",
    "en_drug_common_name": "METFORMIN",
    "fr_drug_brand_name": "APO-METFORMIN ER",
    "fr_drug_common_name": "METFORMIN",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184103,
    "drug": {
      "current_status": "MARKETED",
      "id": 62326,
      "drug_code": 93081,
      "updated_date": "2025-12-03T00:32:54-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261429,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445530",
      "brand_name": "APO-AMPHETAMINE XR",
      "brand_name_fr": "APO-AMPHÉTAMINE XR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310005"
    },
    "created_date": "2023-02-09T16:17:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445530",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2023-04-07T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-06T11:09:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE",
    "fr_drug_brand_name": "APO-AMPHETAMINE",
    "fr_drug_common_name": "AMPHETAMINE",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "AMPHETAMINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184106,
    "drug": {
      "current_status": "MARKETED",
      "id": 16846,
      "drug_code": 77827,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255947,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292920",
      "brand_name": "APO-PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2023-02-09T16:18:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292920",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2023-02-22T00:00:00-05:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-23T12:09:12-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PANTOPRAZOLE",
    "en_drug_common_name": "PANTOPRAZOLE",
    "fr_drug_brand_name": "APO-PANTOPRAZOLE",
    "fr_drug_common_name": "PANTOPRAZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184109,
    "drug": {
      "current_status": "MARKETED",
      "id": 28562,
      "drug_code": 90681,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260362,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422093",
      "brand_name": "APO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485004"
    },
    "created_date": "2023-02-09T16:19:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422093",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2023-02-22T00:00:00-05:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-23T12:12:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "APO-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184112,
    "drug": {
      "current_status": "MARKETED",
      "id": 103341,
      "drug_code": 99800,
      "updated_date": "2022-11-08T06:17:06-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8265853,
          "ingredient": {
            "id": 3440,
            "ingredient_code": 20179,
            "en_name": "SITAGLIPTIN",
            "fr_name": "Sitagliptine (Phosphate de sitagliptine monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02508656",
      "brand_name": "APO-SITAGLIPTIN MALATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152414002"
    },
    "created_date": "2023-02-09T16:21:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02508656",
    "company_name": "APOTEX INC",
    "atc_number": "A10BH",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2023-04-11T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-04-06T11:14:38-04:00",
    "status": "resolved",
    "en_comments": "Product on allocation due to increased demand",
    "fr_comments": "Produit sur allocation en raison d'une demande accrue",
    "en_drug_brand_name": "APO-SITAGLIPTIN MALATE",
    "en_drug_common_name": "SITAGLIPTAN MALATE",
    "fr_drug_brand_name": "APO-SITAGLIPTAN MALATE",
    "fr_drug_common_name": "SITAGLIPTAN MALATE",
    "en_ingredients": "SITAGLIPTIN",
    "fr_ingredients": "SITAGLIPTAN MALATE",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184171,
    "drug": {
      "current_status": "MARKETED",
      "id": 19300,
      "drug_code": 80562,
      "updated_date": "2025-05-15T02:32:18-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256747,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02320177",
      "brand_name": "TEVA-TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2023-02-09T19:34:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02320177",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN 40MG TAB",
    "fr_drug_brand_name": "TEVA-TELMISARTAN 40MG TAB",
    "fr_drug_common_name": "TELMISARTAN 40MG TAB",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100, PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184174,
    "drug": {
      "current_status": "MARKETED",
      "id": 4692,
      "drug_code": 2447,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250414,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00337749",
      "brand_name": "TEVA-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49660",
      "number_of_ais": "1",
      "ai_group_no": "0101944001"
    },
    "created_date": "2023-02-09T19:37:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00337749",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2023-06-20T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FUROSEMIDE",
    "en_drug_common_name": "FUROSEMIDE 40MG TAB",
    "fr_drug_brand_name": "TEVA-FUROSEMIDE 40MG TAB",
    "fr_drug_common_name": "FUROSEMIDE 40MG TAB",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184177,
    "drug": {
      "current_status": "MARKETED",
      "id": 6076,
      "drug_code": 4254,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250613,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00496480",
      "brand_name": "TEVA-PROPRANOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57110",
      "number_of_ais": "1",
      "ai_group_no": "0101831003"
    },
    "created_date": "2023-02-09T19:38:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00496480",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2023-07-30T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-12T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROPRANOLOL",
    "en_drug_common_name": "PROPRANOLOL 10MG TAB",
    "fr_drug_brand_name": "TEVA-PROPRANOLOL 10MG TAB",
    "fr_drug_common_name": "PROPRANOLOL 10MG TAB",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184180,
    "drug": {
      "current_status": "MARKETED",
      "id": 6078,
      "drug_code": 4255,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250614,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00496499",
      "brand_name": "TEVA-PROPRANOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57111",
      "number_of_ais": "1",
      "ai_group_no": "0101831004"
    },
    "created_date": "2023-02-09T19:40:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00496499",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2023-07-10T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-12T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROPRANOLOL",
    "en_drug_common_name": "PROPRANOLOL 40MG TAB",
    "fr_drug_brand_name": "TEVA-PROPRANOLOL 40MG TAB",
    "fr_drug_common_name": "PROPRANOLOL 40MG TAB",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184183,
    "drug": {
      "current_status": "MARKETED",
      "id": 1470,
      "drug_code": 13180,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251731,
          "ingredient": {
            "id": 824,
            "ingredient_code": 1840,
            "en_name": "DOMPERIDONE",
            "fr_name": "Dompéridone (Maléate de dompéridone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01912070",
      "brand_name": "TEVA-DOMPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74486",
      "number_of_ais": "1",
      "ai_group_no": "0116957001"
    },
    "created_date": "2023-02-09T19:41:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01912070",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A03FA",
    "atc_description": "PROPULSIVES",
    "estimated_end_date": "2023-05-20T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DOMPERIDONE",
    "en_drug_common_name": "DOMPERIDONE 10MG TAB",
    "fr_drug_brand_name": "TEVA-DOMPERIDONE 10MG TAB",
    "fr_drug_common_name": "DOMPERIDONE 10MG TAB",
    "en_ingredients": "DOMPERIDONE",
    "fr_ingredients": "DOMPERIDONE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184186,
    "drug": {
      "current_status": "MARKETED",
      "id": 7264,
      "drug_code": 49157,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253258,
          "ingredient": {
            "id": 2338,
            "ingredient_code": 1901,
            "en_name": "MEXILETINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mexilétine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230360",
      "brand_name": "TEVA-MEXILETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116151002"
    },
    "created_date": "2023-02-09T19:44:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230360",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C01BB",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2023-05-10T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MEXILETINE",
    "en_drug_common_name": "MEXILETINE HCL 200MG CAP",
    "fr_drug_brand_name": "TEVA-MEXILETINE HCL 200MG CAP",
    "fr_drug_common_name": "MEXILETINE HCL 200MG CAP",
    "en_ingredients": "MEXILETINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mexilétine",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184189,
    "drug": {
      "current_status": "MARKETED",
      "id": 11570,
      "drug_code": 68492,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254314,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244515",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "400MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2023-02-09T19:46:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244515",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02BF",
    "estimated_end_date": "2023-04-10T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN 400MG CAPS",
    "fr_drug_brand_name": "TEVA-GABAPENTIN 400MG CAPS",
    "fr_drug_common_name": "GABAPENTIN 400MG CAPS",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184192,
    "drug": {
      "current_status": "MARKETED",
      "id": 11952,
      "drug_code": 69789,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254434,
          "ingredient": {
            "id": 838,
            "ingredient_code": 9766,
            "en_name": "SALICYLIC ACID",
            "fr_name": "Acide salicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8254433,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02245688",
      "brand_name": "RATIO-TOPISALIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215695003"
    },
    "created_date": "2023-02-09T19:47:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245688",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07XC",
    "atc_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
    "estimated_end_date": "2023-07-20T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-27T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RATIO-TOPISALIC",
    "en_drug_common_name": "TOPISALIC LOTION",
    "fr_drug_brand_name": "RATIO-TOPISALIC LOTION",
    "fr_drug_common_name": "TOPISALIC LOTION",
    "en_ingredients": "SALICYLIC ACID\r\nBETAMETHASONE",
    "fr_ingredients": "Acide salicylique\r\nBétaméthasone",
    "drug_strength": "20MG\r\n0.5MG",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184195,
    "drug": {
      "current_status": "MARKETED",
      "id": 14012,
      "drug_code": 73989,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255062,
          "ingredient": {
            "id": 1002,
            "ingredient_code": 11385,
            "en_name": "TERBINAFINE",
            "fr_name": "Terbinafine (Chlorhydrate de terbinafine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02254727",
      "brand_name": "TEVA-TERBINAFINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132855002"
    },
    "created_date": "2023-02-09T19:50:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02254727",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D01BA",
    "atc_description": "ANTIFUNGALS FOR SYSTEMIC USE",
    "estimated_end_date": "2023-08-30T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-07-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-05T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT TERBINAFINE",
    "en_drug_common_name": "TERBINAFINE 250MG TAB",
    "fr_drug_brand_name": "ACT-TERBINAFINE 250MG TAB",
    "fr_drug_common_name": "TERBINAFINE 250MG TAB",
    "en_ingredients": "TERBINAFINE",
    "fr_ingredients": "Terbinafine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184198,
    "drug": {
      "current_status": "MARKETED",
      "id": 15838,
      "drug_code": 76587,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255671,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280191",
      "brand_name": "TEVA-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555003"
    },
    "created_date": "2023-02-09T19:51:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02280191",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2023-05-20T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BETAHISTINE",
    "en_drug_common_name": "BETAHISTINE 16MG TAB",
    "fr_drug_brand_name": "TEVA-BETAHISTINE 16MG TAB",
    "fr_drug_common_name": "BETAHISTINE 16MG TAB",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bêta-histine",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184201,
    "drug": {
      "current_status": "MARKETED",
      "id": 15840,
      "drug_code": 76588,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255672,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280205",
      "brand_name": "TEVA-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555004"
    },
    "created_date": "2023-02-09T19:53:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02280205",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2023-06-30T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-07-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-06T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BETAHISTINE",
    "en_drug_common_name": "BETAHISTINE 24MG TAB",
    "fr_drug_brand_name": "TEVA-BETAHISTINE 24MG TAB",
    "fr_drug_common_name": "BETAHISTINE 24MG TAB",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bêta-histine",
    "drug_strength": "24MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184204,
    "drug": {
      "current_status": "MARKETED",
      "id": 17234,
      "drug_code": 78283,
      "updated_date": "2025-12-03T00:31:14-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256079,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02297485",
      "brand_name": "TEVA-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437002"
    },
    "created_date": "2023-02-09T19:55:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02297485",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2023-03-20T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE 5MG TAB",
    "fr_drug_brand_name": "ACT-AMLODIPINE 5MG TAB",
    "fr_drug_common_name": "AMLODIPINE 5MG TAB",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "AMLODIPINE",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184207,
    "drug": {
      "current_status": "MARKETED",
      "id": 18718,
      "drug_code": 79986,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256546,
          "ingredient": {
            "id": 2564,
            "ingredient_code": 11770,
            "en_name": "NARATRIPTAN",
            "fr_name": "Naratriptan (Chlorhydrate de naratriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314304",
      "brand_name": "TEVA-NARATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131121002"
    },
    "created_date": "2023-02-09T19:59:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314304",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-16T19:48:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NARATRIPTAN",
    "en_drug_common_name": "NARATRIPTAN 2.5MG TABS",
    "fr_drug_brand_name": "TEVA-NARATRIPTAN 2.5MG TABS",
    "fr_drug_common_name": "NARATRIPTAN 2.5MG TABS",
    "en_ingredients": "NARATRIPTAN",
    "fr_ingredients": "NARATRIPTAN",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 8",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184210,
    "drug": {
      "current_status": "MARKETED",
      "id": 21090,
      "drug_code": 83386,
      "updated_date": "2025-12-03T00:31:35-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257488,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02348500",
      "brand_name": "TEVA-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2023-02-09T20:12:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02348500",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2023-04-10T00:00:00-04:00",
    "actual_start_date": "2023-02-10T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE 5MG TAB",
    "fr_drug_brand_name": "TEVA-FINASTERIDE 5MG TAB",
    "fr_drug_common_name": "FINASTERIDE 5MG TAB",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184213,
    "drug": {
      "current_status": "MARKETED",
      "id": 25788,
      "drug_code": 88171,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259304,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396688",
      "brand_name": "TEVA-RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841002"
    },
    "created_date": "2023-02-09T20:13:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396688",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN OD 10MG TAB",
    "fr_drug_brand_name": "TEVA-RIZATRIPTAN OD 10MG TAB",
    "fr_drug_common_name": "RIZATRIPTAN OD 10MG TAB",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "RIZATRIPTAN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "pp 6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184216,
    "drug": {
      "current_status": "MARKETED",
      "id": 27056,
      "drug_code": 89301,
      "updated_date": "2025-12-03T00:32:19-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259744,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408287",
      "brand_name": "TEVA-DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "SOFT GELATIN CAPSULE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2023-02-09T20:16:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408287",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2024-05-31T00:00:00-04:00",
    "actual_start_date": "2023-02-08T00:00:00-05:00",
    "actual_end_date": "2024-05-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-30T19:19:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DUTASTERIDE",
    "en_drug_common_name": "DUTASTERIDE 0.5MG CAP",
    "fr_drug_brand_name": "TEVA-DUTASTERIDE 0.5MG CAP",
    "fr_drug_common_name": "DUTASTERIDE 0.5MG CAP",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184219,
    "drug": {
      "current_status": "MARKETED",
      "id": 30308,
      "drug_code": 92362,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261071,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439239",
      "brand_name": "TEVA-AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310001"
    },
    "created_date": "2023-02-09T20:17:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439239",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2023-07-30T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR 5MG CAPS",
    "fr_drug_brand_name": "TEVA-AMPHETAMINE XR 5MG CAPS",
    "fr_drug_common_name": "AMPHETAMINE XR 5MG CAPS",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "AMPHETAMINE",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184222,
    "drug": {
      "current_status": "MARKETED",
      "id": 30316,
      "drug_code": 92366,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261075,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439271",
      "brand_name": "TEVA-AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310005"
    },
    "created_date": "2023-02-09T20:19:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439271",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2023-11-30T00:00:00-05:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-11-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-11-30T16:11:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR 25MG CAPS",
    "fr_drug_brand_name": "TEVA-AMPHETAMINE XR 25MG CAPS",
    "fr_drug_common_name": "AMPHETAMINE XR 25MG CAPS",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "AMPHETAMINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184225,
    "drug": {
      "current_status": "MARKETED",
      "id": 55341,
      "drug_code": 93402,
      "updated_date": "2025-12-03T00:32:56-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261559,
          "ingredient": {
            "id": 1126,
            "ingredient_code": 8298,
            "en_name": "DEXTROAMPHETAMINE SULFATE",
            "fr_name": "Sulfate de dextroamphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02448327",
      "brand_name": "TEVA-DEXTROAMPHETAMINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105933001"
    },
    "created_date": "2023-02-09T20:21:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448327",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2023-05-20T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT DEXTROAMPHETAMINE SR",
    "en_drug_common_name": "DEXTROAMPHETAMINE SRCAP 15MG",
    "fr_drug_brand_name": "ACT-DEXTROAMPHETAMINE SRCAP 15MG",
    "fr_drug_common_name": "DEXTROAMPHETAMINE SRCAP 15MG",
    "en_ingredients": "DEXTROAMPHETAMINE SULFATE",
    "fr_ingredients": "Sulfate de dextroamphétamine",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184230,
    "drug": {
      "current_status": "MARKETED",
      "id": 24614,
      "drug_code": 87203,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258891,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386445",
      "brand_name": "SANDOZ ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434004"
    },
    "created_date": "2023-02-09T21:10:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386445",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-03T21:46:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "SANDOZ ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30HGC",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184233,
    "drug": {
      "current_status": "MARKETED",
      "id": 20304,
      "drug_code": 81805,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257194,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02332396",
      "brand_name": "SANDOZ AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072003"
    },
    "created_date": "2023-02-09T21:12:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02332396",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T21:48:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "SANDOZ AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "22,5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184236,
    "drug": {
      "current_status": "MARKETED",
      "id": 17490,
      "drug_code": 78530,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256166,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299968",
      "brand_name": "SANDOZ ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325002"
    },
    "created_date": "2023-02-09T21:14:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299968",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-03-07T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "SANDOZ ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184240,
    "drug": {
      "current_status": "MARKETED",
      "id": 12500,
      "drug_code": 71196,
      "updated_date": "2025-12-03T00:30:52-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254597,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02246967",
      "brand_name": "SANDOZ ESTRADIOL DERM 50",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457035"
    },
    "created_date": "2023-02-09T21:28:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246967",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-03T00:00:00-05:00",
    "actual_end_date": "2023-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-14T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ESTRADIOL DERM 50",
    "en_drug_common_name": "ESTRADIOL",
    "fr_drug_brand_name": "SANDOZ ESTRADIOL DERM 50",
    "fr_drug_common_name": "ESTRADIOL",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184244,
    "drug": {
      "current_status": "MARKETED",
      "id": 15822,
      "drug_code": 76561,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8255667,
          "ingredient": {
            "id": 3158,
            "ingredient_code": 13348,
            "en_name": "VORICONAZOLE",
            "fr_name": "Voriconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02279991",
      "brand_name": "VFEND",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150242003"
    },
    "created_date": "2023-02-09T21:30:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279991",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "actual_start_date": "2023-02-09T00:00:00-05:00",
    "actual_end_date": "2023-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-28T12:24:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VFEND",
    "en_drug_common_name": "VFEND",
    "fr_drug_brand_name": "VFEND",
    "fr_drug_common_name": "VFEND",
    "en_ingredients": "VORICONAZOLE",
    "fr_ingredients": "Voriconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "70mL BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184251,
    "drug": {
      "current_status": "MARKETED",
      "id": 9776,
      "drug_code": 63824,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253753,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240286",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2023-02-09T21:32:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240286",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-08T00:00:00-05:00",
    "actual_end_date": "2023-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-06T15:56:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184255,
    "drug": {
      "current_status": "MARKETED",
      "id": 11662,
      "drug_code": 68780,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254336,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244790",
      "brand_name": "SANDOZ MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545009"
    },
    "created_date": "2023-02-09T21:34:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244790",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2023-02-27T00:00:00-05:00",
    "actual_start_date": "2023-02-09T00:00:00-05:00",
    "actual_end_date": "2023-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-06T16:16:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR",
    "fr_drug_brand_name": "SANDOZ MORPHINE SR",
    "fr_drug_common_name": "MORPHINE SR",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184259,
    "drug": {
      "current_status": "MARKETED",
      "id": 17876,
      "drug_code": 78939,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256270,
          "ingredient": {
            "id": 3442,
            "ingredient_code": 8280,
            "en_name": "PHENOBARBITAL SODIUM",
            "fr_name": "Phénobarbital sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02304082",
      "brand_name": "PHENOBARBITAL SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105985003"
    },
    "created_date": "2023-02-09T21:37:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02304082",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AA",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-08T00:00:00-05:00",
    "actual_end_date": "2023-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-04T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PHENOBARBITAL SODIUM INJECTION, USP",
    "en_drug_common_name": "PHENOBARBITAL",
    "fr_drug_brand_name": "PHENOBARBITAL SODIUM INJECTION, USP",
    "fr_drug_common_name": "PHENOBARBITAL",
    "en_ingredients": "PHENOBARBITAL SODIUM",
    "fr_ingredients": "Phénobarbital sodique",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184263,
    "drug": {
      "current_status": "MARKETED",
      "id": 12268,
      "drug_code": 70531,
      "updated_date": "2025-05-15T02:31:21-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254521,
          "ingredient": {
            "id": 1368,
            "ingredient_code": 1988,
            "en_name": "TRANEXAMIC ACID",
            "fr_name": "Acide tranexamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02246365",
      "brand_name": "TRANEXAMIC ACID INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114760002"
    },
    "created_date": "2023-02-09T21:38:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246365",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B02AA",
    "atc_description": "ANTIFIBRINOLYTICS",
    "estimated_end_date": "2023-02-24T00:00:00-05:00",
    "actual_start_date": "2023-02-08T00:00:00-05:00",
    "actual_end_date": "2023-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-04T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TRANEXAMIC ACID INJECTION BP",
    "en_drug_common_name": "TRANEXAMIC ACID INJECTION BP",
    "fr_drug_brand_name": "TRANEXAMIC ACID INJECTION BP",
    "fr_drug_common_name": "TRANEXAMIC ACID",
    "en_ingredients": "TRANEXAMIC ACID",
    "fr_ingredients": "Acide tranexamique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184279,
    "drug": {
      "current_status": "MARKETED",
      "id": 32008,
      "drug_code": 9509,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251174,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00786543",
      "brand_name": "DILAUDID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68694",
      "number_of_ais": "1",
      "ai_group_no": "0108698005"
    },
    "created_date": "2023-02-09T21:43:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786543",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2023-02-09T00:00:00-05:00",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-09T00:00:00-05:00",
    "actual_end_date": "2023-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-03-27T12:57:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DILAUDID",
    "en_drug_common_name": "Hydromorphone hydrochloride",
    "fr_drug_brand_name": "DILAUDID",
    "fr_drug_common_name": "Chlorhydrate d'hydromorphone",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184298,
    "drug": {
      "current_status": "MARKETED",
      "id": 54632,
      "drug_code": 95929,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262889,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470314",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548016"
    },
    "created_date": "2023-02-09T21:51:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470314",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2023-02-09T00:00:00-05:00",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2023-02-09T00:00:00-05:00",
    "actual_end_date": "2023-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-02-17T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "45MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184314,
    "drug": {
      "current_status": "MARKETED",
      "id": 162,
      "drug_code": 10440,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251333,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251332,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060747",
      "brand_name": "DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70285",
      "number_of_ais": "2",
      "ai_group_no": "0200203001"
    },
    "created_date": "2023-02-10T14:18:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060747",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2023-02-10T00:00:00-05:00",
    "estimated_end_date": "2023-03-15T00:00:00-04:00",
    "actual_start_date": "2023-02-10T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ",
    "en_drug_common_name": "DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ",
    "fr_drug_brand_name": "Injection de dextrose à 5 % et de chlorure de sodium à 0,9 %",
    "fr_drug_common_name": "Injection de dextrose à 5 % et de chlorure de sodium à 0,9 %",
    "en_ingredients": "SODIUM CHLORIDE\r\nDEXTROSE",
    "fr_ingredients": "Chlorure de sodium\r\nDextrose",
    "drug_strength": "900MG\r\n5G",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "500 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184317,
    "drug": {
      "current_status": "MARKETED",
      "id": 3216,
      "drug_code": 18209,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252274,
          "ingredient": {
            "id": 1376,
            "ingredient_code": 11389,
            "en_name": "LEUCOVORIN",
            "fr_name": "Leucovorine (Leucovorine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02087316",
      "brand_name": "LEUCOVORIN CALCIUM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80432",
      "number_of_ais": "1",
      "ai_group_no": "0108436002"
    },
    "created_date": "2023-02-10T14:37:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02087316",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "V03AF",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2023-02-15T00:00:00-05:00",
    "estimated_end_date": "2023-03-15T00:00:00-04:00",
    "actual_end_date": "2023-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LEUCOVORIN CALCIUM INJECTION",
    "en_drug_common_name": "LEUCOVORIN CALCIUM INJECTION",
    "fr_drug_brand_name": "LEUCOVORIN CALCIUM INJECTION",
    "fr_drug_common_name": "LEUCOVORIN CALCIUM INJECTION",
    "en_ingredients": "LEUCOVORIN",
    "fr_ingredients": "LEUCOVORIN CALCIUM",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184330,
    "drug": {
      "current_status": "MARKETED",
      "id": 18410,
      "drug_code": 79680,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256446,
          "ingredient": {
            "id": 1834,
            "ingredient_code": 7234,
            "en_name": "QUININE SULFATE",
            "fr_name": "Sulfate de quinine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02311216",
      "brand_name": "PRO-QUININE - 200",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106604001"
    },
    "created_date": "2023-02-10T15:09:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02311216",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "P01BC",
    "atc_description": "ANTIMALARIALS",
    "estimated_end_date": "2023-06-21T00:00:00-04:00",
    "actual_start_date": "2023-02-10T00:00:00-05:00",
    "actual_end_date": "2023-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-06-22T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRO-QUININE - 200",
    "en_drug_common_name": "QUININE 200",
    "fr_drug_brand_name": "PRO-QUININE-200",
    "fr_drug_common_name": "QUININE 200",
    "en_ingredients": "QUININE SULFATE",
    "fr_ingredients": "Sulfate de quinine",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184397,
    "drug": {
      "current_status": "MARKETED",
      "id": 57909,
      "drug_code": 96764,
      "updated_date": "2025-05-15T02:36:29-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8263298,
          "ingredient": {
            "id": 6333,
            "ingredient_code": 1915,
            "en_name": "CYCLOSPORINE",
            "fr_name": "Cyclosporine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02476835",
      "brand_name": "RESTASIS MULTIDOSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115996006"
    },
    "created_date": "2023-02-10T19:18:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02476835",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "S01XA",
    "atc_description": "OTHER OPHTHALMOLOGICALS",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-10T00:00:00-05:00",
    "actual_end_date": "2023-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RESTASIS MULTIDOSE",
    "en_drug_common_name": "Restasis 0.05%",
    "fr_drug_brand_name": "RESTASIS",
    "fr_drug_common_name": "Restasis 0.05%",
    "en_ingredients": "CYCLOSPORINE",
    "fr_ingredients": "CYCLOSPORINE",
    "drug_strength": "0.05%",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5.5 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184402,
    "drug": {
      "current_status": "MARKETED",
      "id": 8520,
      "drug_code": 59932,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8253446,
          "ingredient": {
            "id": 1012,
            "ingredient_code": 763,
            "en_name": "ENOXAPARIN SODIUM",
            "fr_name": "Énoxaparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02236564",
      "brand_name": "LOVENOX WITH PRESERVATIVE 300MG/3ML",
      "brand_name_fr": "",
      "descriptor": "MULTIDOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131860001"
    },
    "created_date": "2023-02-10T20:21:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236564",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2023-05-31T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-05-12T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Intermittent supply available\r\nManufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Alimentation intermittente disponible.\r\nRetard de fabrication. \r\nLa date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "LOVENOX WITH PRESERVATIVE 300MG/3ML",
    "en_drug_common_name": "LOVENOX WITH PRESERVATIVE 300MG/3ML",
    "fr_drug_brand_name": "LOVENOX WITH PRESERVATIVE 300MG/3ML",
    "fr_drug_common_name": "LOVENOX WITH PRESERVATIVE 300MG/3ML",
    "en_ingredients": "ENOXAPARIN SODIUM",
    "fr_ingredients": "Énoxaparine sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184405,
    "drug": {
      "current_status": "MARKETED",
      "id": 9222,
      "drug_code": 62114,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8253606,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238682",
      "brand_name": "PLAVIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2023-02-10T20:27:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238682",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2023-03-06T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-02-15T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "PLAVIX",
    "en_drug_common_name": "Plavix 75mg",
    "fr_drug_brand_name": "PLAVIX",
    "fr_drug_common_name": "Plavix 75mg",
    "en_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister of 28 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184409,
    "drug": {
      "current_status": "MARKETED",
      "id": 30566,
      "drug_code": 92621,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8261216,
          "ingredient": {
            "id": 2970,
            "ingredient_code": 12724,
            "en_name": "INSULIN GLARGINE",
            "fr_name": "Insuline glargine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02441829",
      "brand_name": "TOUJEO SOLOSTAR",
      "brand_name_fr": "",
      "descriptor": "1.5ML (450 IU) PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147062002"
    },
    "created_date": "2023-02-10T20:33:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441829",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AE",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2023-03-07T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "actual_end_date": "2023-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-03-08T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Délai en approvisionnement. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "TOUJEO SOLOSTAR",
    "en_drug_common_name": "TOUJEO SOLOSTAR (450 IU)",
    "fr_drug_brand_name": "TOUJEO SOLOSTAR",
    "fr_drug_common_name": "TOUJEO SOLOSTAR (450 IU)",
    "en_ingredients": "INSULIN GLARGINE",
    "fr_ingredients": "Insuline glargine",
    "drug_strength": "300UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "3",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184426,
    "drug": {
      "current_status": "MARKETED",
      "id": 10804,
      "drug_code": 66635,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254082,
          "ingredient": {
            "id": 2312,
            "ingredient_code": 9011,
            "en_name": "SCOPOLAMINE HYDROBROMIDE",
            "fr_name": "Bromhydrate de scopolamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242810",
      "brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104674001"
    },
    "created_date": "2023-02-10T22:53:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242810",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "N05CM",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-10T00:00:00-05:00",
    "actual_end_date": "2023-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
    "en_drug_common_name": "Scopolamine Hydrobromide Injection",
    "fr_drug_brand_name": "Injection De Bromhydrate De Scopolamine",
    "fr_drug_common_name": "Injection De Bromhydrate De Scopolamine",
    "en_ingredients": "SCOPOLAMINE HYDROBROMIDE",
    "fr_ingredients": "Bromhydrate de scopolamine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184429,
    "drug": {
      "current_status": "MARKETED",
      "id": 12884,
      "drug_code": 72016,
      "updated_date": "2025-05-15T02:31:27-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254719,
          "ingredient": {
            "id": 916,
            "ingredient_code": 1395,
            "en_name": "FAMOTIDINE",
            "fr_name": "Famotidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02247735",
      "brand_name": "FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118722003"
    },
    "created_date": "2023-02-10T23:02:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247735",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2023-03-21T00:00:00-04:00",
    "actual_start_date": "2023-02-17T00:00:00-05:00",
    "actual_end_date": "2023-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-22T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FAMOTIDINE OMEGA  -(WITHOUT PRESERVATIVE)",
    "en_drug_common_name": "Famotidine Injection",
    "fr_drug_brand_name": "Famotidine Omega",
    "fr_drug_common_name": "Famotidine Injection",
    "en_ingredients": "FAMOTIDINE",
    "fr_ingredients": "Famotidine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 2 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184432,
    "drug": {
      "current_status": "MARKETED",
      "id": 25322,
      "drug_code": 87801,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8259177,
          "ingredient": {
            "id": 1368,
            "ingredient_code": 1988,
            "en_name": "TRANEXAMIC ACID",
            "fr_name": "Acide tranexamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02392763",
      "brand_name": "TRANEXAMIC ACID INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114760002"
    },
    "created_date": "2023-02-10T23:08:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392763",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B02AA",
    "atc_description": "ANTIFIBRINOLYTICS",
    "estimated_end_date": "2023-04-17T00:00:00-04:00",
    "actual_start_date": "2023-02-17T00:00:00-05:00",
    "actual_end_date": "2023-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-04-18T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRANEXAMIC ACID INJECTION",
    "en_drug_common_name": "Tranexamic Acid Injection",
    "fr_drug_brand_name": "Acide Tranexamique Injectable",
    "fr_drug_common_name": "Acide Tranexamique Injectable",
    "en_ingredients": "TRANEXAMIC ACID",
    "fr_ingredients": "Acide tranexamique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 x 50mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184454,
    "drug": {
      "current_status": "MARKETED",
      "id": 2628,
      "drug_code": 16262,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 12055,
        "created_date": "2019-01-08T03:00:03-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 17454,
        "mfr_code": "",
        "name": "PHARMA STULLN INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6500 TRANS CANADA HIGHWAY, SUITE 400",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 0A5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252107,
          "ingredient": {
            "id": 662,
            "ingredient_code": 7598,
            "en_name": "DEXAMETHASONE SODIUM PHOSPHATE",
            "fr_name": "Phosphate de dexaméthasone sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02023865",
      "brand_name": "DEXAMETHASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78142",
      "number_of_ais": "1",
      "ai_group_no": "0131220004"
    },
    "created_date": "2023-02-13T07:37:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02023865",
    "company_name": "PHARMA STULLN INC.",
    "atc_number": "S03BA",
    "atc_description": "CORTICOSTEROIDS",
    "anticipated_start_date": "2023-02-13T00:00:00-05:00",
    "estimated_end_date": "2023-05-30T00:00:00-04:00",
    "actual_start_date": "2023-02-13T00:00:00-05:00",
    "actual_end_date": "2023-07-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-07-07T17:15:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXAMETHASONE",
    "en_drug_common_name": "Dexamethasone",
    "fr_drug_brand_name": "Dexamethasone",
    "fr_drug_common_name": "Dexamethasone",
    "en_ingredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "fr_ingredients": "Phosphate de dexaméthasone sodique",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Solution\r\nSolution",
    "drug_route": "OTIC\r\nOPHTHALMIC\r\nOTIC\r\nOPHTHALMIC",
    "drug_route_fr": "Otique\r\nOphtalmique\r\nOtique\r\nOphtalmique",
    "drug_package_quantity": "Dexamethasone 0.1% 5ml bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184472,
    "drug": {
      "current_status": "MARKETED",
      "id": 12374,
      "drug_code": 70814,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8254556,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246624",
      "brand_name": "COVERSYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127178003"
    },
    "created_date": "2023-02-13T15:18:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246624",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2023-02-14T00:00:00-05:00",
    "estimated_end_date": "2023-02-24T00:00:00-05:00",
    "actual_end_date": "2023-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-02-17T14:32:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "COVERSYL",
    "en_drug_common_name": "Perindopril Erbumine",
    "fr_drug_brand_name": "Coversyl",
    "fr_drug_common_name": "Perindopril Erbumine",
    "en_ingredients": "PERINDOPRIL ERBUMINE",
    "fr_ingredients": "Périndopril erbumine",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184493,
    "drug": {
      "current_status": "MARKETED",
      "id": 15592,
      "drug_code": 76281,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255590,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277166",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548001"
    },
    "created_date": "2023-02-13T19:23:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277166",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2023-02-13T00:00:00-05:00",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2023-02-13T00:00:00-05:00",
    "actual_end_date": "2023-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-02-17T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184496,
    "drug": {
      "current_status": "MARKETED",
      "id": 3612,
      "drug_code": 19050,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252412,
          "ingredient": {
            "id": 1516,
            "ingredient_code": 6750,
            "en_name": "CODEINE",
            "fr_name": "Codéine (Phosphate de codéine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02163748",
      "brand_name": "CODEINE CONTIN 100MG CONTROLLED RELEASE TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81339",
      "number_of_ais": "1",
      "ai_group_no": "0153086004"
    },
    "created_date": "2023-02-13T19:25:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02163748",
    "company_name": "PURDUE PHARMA",
    "atc_number": "R05DA",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "anticipated_start_date": "2023-02-13T00:00:00-05:00",
    "estimated_end_date": "2023-06-16T00:00:00-04:00",
    "actual_start_date": "2023-02-13T00:00:00-05:00",
    "actual_end_date": "2023-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-06-10T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CODEINE CONTIN 100MG CONTROLLED RELEASE TAB",
    "en_drug_common_name": "Codeine Controlled Release Tablets",
    "fr_drug_brand_name": "CODEINE CONTIN",
    "fr_drug_common_name": "Comprimés de codéine à libération contrôlée",
    "en_ingredients": "CODEINE",
    "fr_ingredients": "Codéine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184528,
    "drug": {
      "current_status": "MARKETED",
      "id": 3918,
      "drug_code": 19553,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252510,
          "ingredient": {
            "id": 1574,
            "ingredient_code": 135,
            "en_name": "GANCICLOVIR",
            "fr_name": "Ganciclovir (Ganciclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02162695",
      "brand_name": "CYTOVENE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81850",
      "number_of_ais": "1",
      "ai_group_no": "0128037002"
    },
    "created_date": "2023-02-14T14:49:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02162695",
    "company_name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2024-03-31T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2024-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-14T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CYTOVENE",
    "en_drug_common_name": "ganciclovir for injection",
    "fr_drug_brand_name": "Cytovene",
    "fr_drug_common_name": "ganciclovir pour injection",
    "en_ingredients": "GANCICLOVIR",
    "fr_ingredients": "Ganciclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "500 mg/vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184549,
    "drug": {
      "current_status": "MARKETED",
      "id": 326,
      "drug_code": 1086,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250231,
          "ingredient": {
            "id": 252,
            "ingredient_code": 10209,
            "en_name": "PHENYTOIN",
            "fr_name": "Phénytoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00023698",
      "brand_name": "DILANTIN INFATABS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "35496",
      "number_of_ais": "1",
      "ai_group_no": "0101372003"
    },
    "created_date": "2023-02-14T17:16:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00023698",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "N03AB",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2023-05-09T00:00:00-04:00",
    "actual_start_date": "2022-12-22T00:00:00-05:00",
    "actual_end_date": "2022-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-20T16:37:47-04:00",
    "status": "resolved",
    "en_comments": "closed due to duplicate entries of this DIN",
    "en_drug_brand_name": "DILANTIN INFATABS",
    "en_drug_common_name": "DILANTIN INFATABS",
    "fr_drug_brand_name": "DILANTIN INFATABS",
    "fr_drug_common_name": "DILANTIN INFATABS",
    "en_ingredients": "PHENYTOIN",
    "fr_ingredients": "Phénytoïne",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184552,
    "drug": {
      "current_status": "MARKETED",
      "id": 3124,
      "drug_code": 18005,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252237,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02132702",
      "brand_name": "ZOLOFT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80217",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2023-02-14T17:18:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02132702",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-03-14T00:00:00-04:00",
    "actual_start_date": "2023-02-07T00:00:00-05:00",
    "actual_end_date": "2023-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-20T16:36:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOLOFT",
    "en_drug_common_name": "ZOLFT",
    "fr_drug_brand_name": "ZOLOFT",
    "fr_drug_common_name": "ZOLOFT",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184556,
    "drug": {
      "current_status": "MARKETED",
      "id": 15332,
      "drug_code": 75877,
      "updated_date": "2025-12-03T00:31:05-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255483,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8255482,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02273284",
      "brand_name": "CADUET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555005"
    },
    "created_date": "2023-02-14T17:19:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02273284",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "anticipated_start_date": "2023-03-01T00:00:00-05:00",
    "estimated_end_date": "2023-03-07T00:00:00-05:00",
    "actual_end_date": "2023-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-20T16:34:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CADUET",
    "en_drug_common_name": "CADUET",
    "fr_drug_brand_name": "CADUET",
    "fr_drug_common_name": "CADUET",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "drug_strength": "10MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184559,
    "drug": {
      "current_status": "MARKETED",
      "id": 14956,
      "drug_code": 75381,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255352,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02268434",
      "brand_name": "LYRICA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2023-02-14T17:20:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02268434",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "N02BF",
    "anticipated_start_date": "2023-03-09T00:00:00-05:00",
    "actual_start_date": "2023-03-14T00:00:00-04:00",
    "actual_end_date": "2023-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-13T12:31:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LYRICA",
    "en_drug_common_name": "LYRICA",
    "fr_drug_brand_name": "LYRICA",
    "fr_drug_common_name": "LYRICA",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184568,
    "drug": {
      "current_status": "MARKETED",
      "id": 49642,
      "drug_code": 92813,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261324,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261323,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443449",
      "brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED-RELEASE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252870002"
    },
    "created_date": "2023-02-14T18:36:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443449",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2023-02-24T00:00:00-05:00",
    "estimated_end_date": "2023-03-23T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-27T18:57:21-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "en_drug_common_name": "NAPROXEN/ESOMEPRAZOLE",
    "fr_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "fr_drug_common_name": "NAPROXEN/ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE\r\nNAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "20MG\r\n500MG",
    "drug_dosage_form": "TABLET (IMMEDIATE AND DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate et retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184576,
    "drug": {
      "current_status": "MARKETED",
      "id": 11774,
      "drug_code": 69229,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254373,
          "ingredient": {
            "id": 32869,
            "ingredient_code": 645,
            "en_name": "ASCORBIC ACID",
            "fr_name": "Acide ascorbique (Acide ascorbique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02245214",
      "brand_name": "VITAMIN C",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108469006"
    },
    "created_date": "2023-02-14T18:46:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245214",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A11GA",
    "atc_description": "ASCORBIC ACID (VIT C), INCL COMBINATIONS",
    "estimated_end_date": "2023-02-28T00:00:00-05:00",
    "actual_start_date": "2023-02-10T00:00:00-05:00",
    "actual_end_date": "2023-02-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T23:10:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VITAMIN C",
    "en_drug_common_name": "ASCORBIC ACID",
    "fr_drug_brand_name": "VITAMIN C",
    "fr_drug_common_name": "ASCORBIC ACID",
    "en_ingredients": "ASCORBIC ACID",
    "fr_ingredients": "ASCORBIC ACID",
    "drug_strength": "500MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "50ML 1VL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184582,
    "drug": {
      "current_status": "MARKETED",
      "id": 30900,
      "drug_code": 93037,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261421,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "MG",
          "base": false
        },
        {
          "id": 8261420,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "MG",
          "base": false
        },
        {
          "id": 8261419,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "MG",
          "base": false
        }
      ],
      "din": "02445158",
      "brand_name": "CREON MINIMICROSPHERES MICRO",
      "brand_name_fr": "CREON MINIMICROSPHÈRES MICRO",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0302964039"
    },
    "created_date": "2023-02-14T18:49:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445158",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2023-02-23T00:00:00-05:00",
    "estimated_end_date": "2023-03-14T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-20T17:29:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CREON MINIMICROSPHERES MICRO",
    "en_drug_common_name": "CREON MINIMICROSPHERES MICRO",
    "fr_drug_brand_name": "CREON MINIMICROSPHERES MICRO",
    "fr_drug_common_name": "CREON MINIMICROSPHERES MICRO",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "320UNIT\r\n5100UNIT\r\n5000UNIT",
    "drug_dosage_form": "GRANULES FOR SUSPENSION, DELAYED RELEASE",
    "drug_dosage_form_fr": "Granules pour suspension, à libération retardée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "20G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184615,
    "drug": {
      "current_status": "MARKETED",
      "id": 2906,
      "drug_code": 17104,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8252182,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02099233",
      "brand_name": "GLUCOPHAGE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79254",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2023-02-14T19:14:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02099233",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2023-06-30T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-06-23T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "GLUCOPHAGE",
    "en_drug_common_name": "GLUCOPHAGE 500 mg",
    "fr_drug_brand_name": "GLUCOPHAGE",
    "fr_drug_common_name": "Glucophage 500 mg",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184619,
    "drug": {
      "current_status": "MARKETED",
      "id": 24692,
      "drug_code": 87272,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258915,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387131",
      "brand_name": "SANDOZ CIPROFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207004"
    },
    "created_date": "2023-02-14T19:20:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387131",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01AE",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2023-04-07T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2023-04-05T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CIPROFLOXACIN",
    "en_drug_common_name": "CIPROFLOXACIN",
    "fr_drug_brand_name": "SANDOZ CIPROFLOXACIN",
    "fr_drug_common_name": "CIPROFLOXACIN",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "0.3%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184624,
    "drug": {
      "current_status": "MARKETED",
      "id": 10540,
      "drug_code": 6593,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8250917,
          "ingredient": {
            "id": 304,
            "ingredient_code": 12030,
            "en_name": "DEXAMETHASONE PHOSPHATE",
            "fr_name": "Phosphate de dexaméthasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00664227",
      "brand_name": "DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63544",
      "number_of_ais": "1",
      "ai_group_no": "0106305003"
    },
    "created_date": "2023-02-14T19:21:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00664227",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2023-06-02T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML",
    "en_drug_common_name": "DEXAMETHASONE",
    "fr_drug_brand_name": "SANDOZ DEXAMETHASONE",
    "fr_drug_common_name": "DEXAMETHASONE",
    "en_ingredients": "DEXAMETHASONE PHOSPHATE",
    "fr_ingredients": "Phosphate de dexaméthasone",
    "drug_strength": "4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRASYNOVIAL\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRASYNOVIAL\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntrasynoviale\r\nIntramusculaire\r\nIntraveineuse\r\nIntrasynoviale\r\nIntramusculaire",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184628,
    "drug": {
      "current_status": "MARKETED",
      "id": 10362,
      "drug_code": 65502,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253917,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        },
        {
          "id": 8253916,
          "ingredient": {
            "id": 1006,
            "ingredient_code": 7498,
            "en_name": "NORETHINDRONE ACETATE",
            "fr_name": "Acétate de noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "140",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02241835",
      "brand_name": "ESTALIS 140/50 MCG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242942005"
    },
    "created_date": "2023-02-14T19:23:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241835",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03FA",
    "atc_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-03-03T21:48:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTALIS 140/50 MCG",
    "en_drug_common_name": "ESTALIS",
    "fr_drug_brand_name": "ESTALIS 140/50 MCG",
    "fr_drug_common_name": "ESTALIS",
    "en_ingredients": "NORETHINDRONE ACETATE\r\nESTRADIOL",
    "fr_ingredients": "Acétate de noréthindrone\r\nEstradiol",
    "drug_strength": "140MCG\r\n50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTSM",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184632,
    "drug": {
      "current_status": "MARKETED",
      "id": 20570,
      "drug_code": 82303,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257278,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257277,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337444",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2023-02-14T19:24:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "IRBESARTAN HCT",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_common_name": "IRBESARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184636,
    "drug": {
      "current_status": "MARKETED",
      "id": 11260,
      "drug_code": 67670,
      "updated_date": "2025-05-15T02:31:15-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254225,
          "ingredient": {
            "id": 2844,
            "ingredient_code": 5974,
            "en_name": "PHENTOLAMINE MESYLATE",
            "fr_name": "Mésylate de phentolamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243737",
      "brand_name": "PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107611001"
    },
    "created_date": "2023-02-14T19:26:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243737",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C04AB",
    "atc_description": "PERIPHERALVASODILATORS",
    "estimated_end_date": "2023-02-24T00:00:00-05:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T21:50:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD",
    "en_drug_common_name": "PHENTOLAMINE",
    "fr_drug_brand_name": "PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD",
    "fr_drug_common_name": "PHENTOLAMINE",
    "en_ingredients": "PHENTOLAMINE MESYLATE",
    "fr_ingredients": "Mésylate de phentolamine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184639,
    "drug": {
      "current_status": "MARKETED",
      "id": 18704,
      "drug_code": 79974,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256541,
          "ingredient": {
            "id": 2884,
            "ingredient_code": 12149,
            "en_name": "RABEPRAZOLE SODIUM",
            "fr_name": "Rabéprazole sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314177",
      "brand_name": "SANDOZ RABEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143681001"
    },
    "created_date": "2023-02-14T19:27:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314177",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-03T21:55:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ RABEPRAZOLE",
    "en_drug_common_name": "RABEPRAZOLE",
    "fr_drug_brand_name": "SANDOZ RABEPRAZOLE",
    "fr_drug_common_name": "RABEPRAZOLE",
    "en_ingredients": "RABEPRAZOLE SODIUM",
    "fr_ingredients": "Rabéprazole sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100GRT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184642,
    "drug": {
      "current_status": "MARKETED",
      "id": 2906,
      "drug_code": 17104,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8252182,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02099233",
      "brand_name": "GLUCOPHAGE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79254",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2023-02-14T19:29:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02099233",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2023-06-30T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-06-23T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "GLUCOPHAGE",
    "en_drug_common_name": "GLUCOPHAGE 500 mg",
    "fr_drug_brand_name": "GLUCOPHAGE",
    "fr_drug_common_name": "Glucophage 500 mg",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184644,
    "drug": {
      "current_status": "MARKETED",
      "id": 12424,
      "drug_code": 70996,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254573,
          "ingredient": {
            "id": 548,
            "ingredient_code": 11190,
            "en_name": "KETAMINE",
            "fr_name": "Kétamine (Chlorhydrate de kétamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02246796",
      "brand_name": "KETAMINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131360003"
    },
    "created_date": "2023-02-14T19:29:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246796",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N01AX",
    "atc_description": "ANESTHETICS, GENERAL",
    "estimated_end_date": "2023-07-14T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-30T14:37:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "KETAMINE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "KETAMINE HCL",
    "fr_drug_brand_name": "KETAMINE HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "KETAMINE HCL",
    "en_ingredients": "KETAMINE",
    "fr_ingredients": "KETAMINE HCL",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184712,
    "drug": {
      "current_status": "MARKETED",
      "id": 10370,
      "drug_code": 65559,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8253921,
          "ingredient": {
            "id": 2776,
            "ingredient_code": 11980,
            "en_name": "LEFLUNOMIDE",
            "fr_name": "Léflunomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241889",
      "brand_name": "ARAVA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140182002"
    },
    "created_date": "2023-02-15T21:26:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241889",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2023-06-30T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-06-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-06-14T17:07:22-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "ARAVA",
    "en_drug_common_name": "ARAVA 20 mg",
    "fr_drug_brand_name": "ARAVA",
    "fr_drug_common_name": "ARAVA 20 mg",
    "en_ingredients": "LEFLUNOMIDE",
    "fr_ingredients": "Léflunomide",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottle of 30 tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184721,
    "drug": {
      "current_status": "MARKETED",
      "id": 5656,
      "drug_code": 37375,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8252905,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02224755",
      "brand_name": "LASIX SPECIAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4906",
      "number_of_ais": "1",
      "ai_group_no": "0101944006"
    },
    "created_date": "2023-02-15T21:31:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02224755",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-03-16T18:41:31-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "LASIX SPECIAL",
    "en_drug_common_name": "LASIX SPECIAL",
    "fr_drug_brand_name": "LASIX SPECIAL",
    "fr_drug_common_name": "LASIX SPECIAL",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottle of 20 tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184729,
    "drug": {
      "current_status": "MARKETED",
      "id": 6564,
      "drug_code": 43511,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8253096,
          "ingredient": {
            "id": 198,
            "ingredient_code": 7581,
            "en_name": "BUDESONIDE",
            "fr_name": "Budésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02229099",
      "brand_name": "PULMICORT NEBUAMP 0.125 MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9852",
      "number_of_ais": "1",
      "ai_group_no": "0116807005"
    },
    "created_date": "2023-02-16T12:22:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229099",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2023-04-05T00:00:00-04:00",
    "actual_start_date": "2023-02-15T00:00:00-05:00",
    "actual_end_date": "2023-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-04-06T11:08:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PULMICORT NEBUAMP 0.125 MG/ML",
    "en_drug_common_name": "budesonide",
    "fr_drug_brand_name": "PULMICORT NEBUAMP",
    "fr_drug_common_name": "budésonide",
    "en_ingredients": "BUDESONIDE",
    "fr_ingredients": "Budésonide",
    "drug_strength": "0.125MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20 ampoules",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184738,
    "drug": {
      "current_status": "MARKETED",
      "id": 59325,
      "drug_code": 97066,
      "updated_date": "2025-05-15T02:36:40-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263553,
          "ingredient": {
            "id": 25315,
            "ingredient_code": 9107,
            "en_name": "METHIMAZOLE",
            "fr_name": "Méthimazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02480107",
      "brand_name": "MAR-METHIMAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104552001"
    },
    "created_date": "2023-02-16T14:40:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02480107",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "H03BB",
    "atc_description": "ANTITHYROID PREPARATIONS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-16T00:00:00-05:00",
    "actual_end_date": "2023-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2023-03-10T13:14:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-METHIMAZOLE",
    "en_drug_common_name": "MAR-Methimazole",
    "fr_drug_brand_name": "MAR-Methimazole",
    "fr_drug_common_name": "MAR-Methimazole",
    "en_ingredients": "METHIMAZOLE",
    "fr_ingredients": "Methimazole",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184782,
    "drug": {
      "current_status": "MARKETED",
      "id": 5270,
      "drug_code": 3395,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250508,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "234",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00402230",
      "brand_name": "SODIUM CHLORIDE INJ 23.4%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54172",
      "number_of_ais": "1",
      "ai_group_no": "0100053008"
    },
    "created_date": "2023-02-16T15:50:54-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00402230",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "discontinuation_date": "2023-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "No product inventory is available.",
    "fr_supply_disruption_mitigation": "Produit non disponible.",
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2023-02-17T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SODIUM CHLORIDE INJ 23.4%",
    "en_drug_common_name": "SODIUM CHLORIDE INJ 23.4%",
    "fr_drug_brand_name": "SODIUM CHLORIDE INJ 23.4%",
    "fr_drug_common_name": "SODIUM CHLORIDE INJ 23.4%",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "234MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 X 30ML VIALS / FIOLES",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184792,
    "drug": {
      "current_status": "MARKETED",
      "id": 60212,
      "drug_code": 96397,
      "updated_date": "2025-05-15T02:36:22-04:00",
      "company": {
        "id": 140,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 4835,
        "mfr_code": "ODN07",
        "name": "ODAN LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "325 STILLVIEW AVENUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 2Y6",
        "post_office_box": "",
        "contact_information": "info@odanlab.com\r\nTel.: 1-800-387-9342\r\nFax: 1-800-329-6326"
      },
      "drug_ingredients": [
        {
          "id": 8263147,
          "ingredient": {
            "id": 1334,
            "ingredient_code": 4028,
            "en_name": "SODIUM POLYSTYRENE SULFONATE",
            "fr_name": "Polystyrène sulfonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02473968",
      "brand_name": "ODAN-SODIUM POLYSTYRENE SULFONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108701001"
    },
    "created_date": "2023-02-16T19:26:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02473968",
    "company_name": "ODAN LABORATORIES LTD",
    "atc_number": "V03AE",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2023-03-30T00:00:00-04:00",
    "actual_start_date": "2023-02-15T00:00:00-05:00",
    "actual_end_date": "2023-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-27T13:53:44-04:00",
    "status": "resolved",
    "en_comments": "current inventory on allocation",
    "fr_comments": "inventaire courant en allocation",
    "en_drug_brand_name": "ODAN-SODIUM POLYSTYRENE SULFONATE",
    "en_drug_common_name": "Sodium Polystyrene Sulfonate Oral/Rectal Suspension",
    "fr_drug_brand_name": "ODAN-SODIUM POLYSTYRENE SULFONATE",
    "fr_drug_common_name": "Suspension orale/rectale de sulfonate de polystyrène sodique",
    "en_ingredients": "SODIUM POLYSTYRENE SULFONATE",
    "fr_ingredients": "Polystyrène sulfonate de sodium",
    "drug_strength": "250MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "RECTAL\r\nORAL\r\nRECTAL\r\nORAL",
    "drug_route_fr": "Rectale\r\nOrale\r\nRectale\r\nOrale",
    "drug_package_quantity": "60 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184916,
    "drug": {
      "current_status": "MARKETED",
      "id": 7558,
      "drug_code": 50297,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253342,
          "ingredient": {
            "id": 1120,
            "ingredient_code": 10196,
            "en_name": "NITROFURANTOIN",
            "fr_name": "Nitrofurantoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231016",
      "brand_name": "TEVA-NITROFURANTOIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101480001"
    },
    "created_date": "2023-02-16T20:45:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231016",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01XE",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2023-03-20T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NITROFURANTOIN",
    "en_drug_common_name": "TEVA-NITROFURANTOIN 100MG CAPS",
    "fr_drug_brand_name": "TEVA-NITROFURANTOIN 100MG CAPS",
    "fr_drug_common_name": "NITROFURANTOIN 100MG CAPS",
    "en_ingredients": "NITROFURANTOIN",
    "fr_ingredients": "Nitrofurantoïne",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184919,
    "drug": {
      "current_status": "MARKETED",
      "id": 98310,
      "drug_code": 91375,
      "updated_date": "2020-04-03T06:52:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260652,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429322",
      "brand_name": "TEVA-DILTIAZEM XC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2023-02-16T20:51:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429322",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2023-03-20T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM XC",
    "en_drug_common_name": "DILTIAZEM XC 180MG TAB",
    "fr_drug_brand_name": "TEVA-DILTIAZEM XC 180MG TAB",
    "fr_drug_common_name": "DILTIAZEM XC 180MG TAB",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184922,
    "drug": {
      "current_status": "MARKETED",
      "id": 98311,
      "drug_code": 91376,
      "updated_date": "2020-04-03T06:52:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260653,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429330",
      "brand_name": "TEVA-DILTIAZEM XC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863006"
    },
    "created_date": "2023-02-16T20:52:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429330",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2023-03-20T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM XC",
    "en_drug_common_name": "DILTIAZEM XC 240MG TAB",
    "fr_drug_brand_name": "TEVA-DILTIAZEM XC 240MG TAB",
    "fr_drug_common_name": "DILTIAZEM XC 240MG TAB",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "240MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184925,
    "drug": {
      "current_status": "MARKETED",
      "id": 98312,
      "drug_code": 91377,
      "updated_date": "2020-04-03T06:52:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260654,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429349",
      "brand_name": "TEVA-DILTIAZEM XC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863008"
    },
    "created_date": "2023-02-16T20:53:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429349",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2023-03-20T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM XC",
    "en_drug_common_name": "DILTIAZEM XC 300MG TAB",
    "fr_drug_brand_name": "TEVA-DILTIAZEM XC 300MG TAB",
    "fr_drug_common_name": "DILTIAZEM XC 300MG TAB",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184928,
    "drug": {
      "current_status": "MARKETED",
      "id": 56312,
      "drug_code": 94027,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261871,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02453738",
      "brand_name": "TEVA-FLUTICASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685001"
    },
    "created_date": "2023-02-16T20:55:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453738",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2023-03-20T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FLUTICASONE",
    "en_drug_common_name": "FLUTICASONE 50MCG SPRAY",
    "fr_drug_brand_name": "TEVA-FLUTICASONE 50MCG SPRAY",
    "fr_drug_common_name": "FLUTICASONE 50MCG SPRAY",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "METERED-DOSE PUMP",
    "drug_dosage_form_fr": "Pompe à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184931,
    "drug": {
      "current_status": "MARKETED",
      "id": 56752,
      "drug_code": 95023,
      "updated_date": "2025-05-15T02:35:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262422,
          "ingredient": {
            "id": 6333,
            "ingredient_code": 1915,
            "en_name": "CYCLOSPORINE",
            "fr_name": "Cyclosporine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02462486",
      "brand_name": "TEVA-CYCLOSPORINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115996006"
    },
    "created_date": "2023-02-16T20:56:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02462486",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "S01XA",
    "atc_description": "OTHER OPHTHALMOLOGICALS",
    "estimated_end_date": "2023-07-30T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-08-04T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CYCLOSPORINE",
    "en_drug_common_name": "CYCLOSPORINE 0.05% OPH SOLN",
    "fr_drug_brand_name": "TEVA-CYCLOSPORINE 0.05% OPH SOLN",
    "fr_drug_common_name": "CYCLOSPORINE 0.05% OPH SOLN",
    "en_ingredients": "CYCLOSPORINE",
    "fr_ingredients": "CYCLOSPORINE",
    "drug_strength": "0.05%",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "0.4ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184934,
    "drug": {
      "current_status": "MARKETED",
      "id": 2124,
      "drug_code": 14504,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251972,
          "ingredient": {
            "id": 1080,
            "ingredient_code": 2023,
            "en_name": "SUCRALFATE",
            "fr_name": "Sucralfate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02045702",
      "brand_name": "TEVA-SUCRALFATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76137",
      "number_of_ais": "1",
      "ai_group_no": "0114237002"
    },
    "created_date": "2023-02-16T20:57:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02045702",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BX",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2023-05-30T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SUCRALFATE",
    "en_drug_common_name": "SUCRALFATE 1GM TAB",
    "fr_drug_brand_name": "TEVA-SUCRALFATE 1GM TAB",
    "fr_drug_common_name": "SUCRALFATE 1GM TAB",
    "en_ingredients": "SUCRALFATE",
    "fr_ingredients": "Sucralfate",
    "drug_strength": "1G",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184937,
    "drug": {
      "current_status": "MARKETED",
      "id": 2690,
      "drug_code": 16507,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252132,
          "ingredient": {
            "id": 1254,
            "ingredient_code": 1998,
            "en_name": "ETOPOSIDE",
            "fr_name": "Étoposide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02080036",
      "brand_name": "ETOPOSIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78403",
      "number_of_ais": "1",
      "ai_group_no": "0114567002"
    },
    "created_date": "2023-02-16T20:59:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02080036",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01CB",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "estimated_end_date": "2023-06-30T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ETOPOSIDE INJECTION",
    "en_drug_common_name": "ETOPOSIDE INJECTION 20MG/ML",
    "fr_drug_brand_name": "ETOPOSIDE INJECTION 20MG/ML",
    "fr_drug_common_name": "ETOPOSIDE INJECTION 20MG/ML",
    "en_ingredients": "ETOPOSIDE",
    "fr_ingredients": "Étoposide",
    "drug_strength": "20MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184940,
    "drug": {
      "current_status": "MARKETED",
      "id": 25624,
      "drug_code": 88038,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259254,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395274",
      "brand_name": "TEVA-TEMOZOLOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781002"
    },
    "created_date": "2023-02-16T21:00:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395274",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE 20MG CAPS",
    "fr_drug_brand_name": "ACT-TEMOZOLOMIDE 20MG CAPS",
    "fr_drug_common_name": "TEMOZOLOMIDE 20MG CAPS",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184943,
    "drug": {
      "current_status": "MARKETED",
      "id": 30400,
      "drug_code": 92454,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261106,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440164",
      "brand_name": "TEVA-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "FOR ON-DEMAND DOSING",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485001"
    },
    "created_date": "2023-02-16T21:02:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440164",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2023-04-10T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TADALAFIL",
    "en_drug_common_name": "TADALAFIL 10MG TAB",
    "fr_drug_brand_name": "TEVA-TADALAFIL 10MG TAB",
    "fr_drug_common_name": "TADALAFIL 10MG TAB",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 p pak",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184946,
    "drug": {
      "current_status": "MARKETED",
      "id": 2218,
      "drug_code": 14713,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251990,
          "ingredient": {
            "id": 270,
            "ingredient_code": 2564,
            "en_name": "CLONIDINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de clonidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02046148",
      "brand_name": "TEVA-CLONIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76381",
      "number_of_ais": "1",
      "ai_group_no": "0108891002"
    },
    "created_date": "2023-02-16T21:03:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02046148",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C02AC",
    "atc_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
    "estimated_end_date": "2023-09-20T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-04T13:33:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLONIDINE",
    "en_drug_common_name": "CLONIDINE 0.2MG TAB",
    "fr_drug_brand_name": "TEVA-CLONIDINE 0.2MG TAB",
    "fr_drug_common_name": "CLONIDINE 0.2MG TAB",
    "en_ingredients": "CLONIDINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de clonidine",
    "drug_strength": "0.2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184949,
    "drug": {
      "current_status": "MARKETED",
      "id": 13650,
      "drug_code": 7349,
      "updated_date": "2025-05-15T02:30:39-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251011,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00740675",
      "brand_name": "TEVA-PROPRANOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65238",
      "number_of_ais": "1",
      "ai_group_no": "0101831005"
    },
    "created_date": "2023-02-16T21:05:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00740675",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2023-07-10T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-07-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-06T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROPRANOLOL",
    "en_drug_common_name": "PROPRANOLOL 20MG TAB",
    "fr_drug_brand_name": "TEVA-PROPRANOLOL 20MG TAB",
    "fr_drug_common_name": "PROPRANOLOL 20MG TAB",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 184959,
    "drug": {
      "current_status": "MARKETED",
      "id": 5096,
      "drug_code": 3088,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8250483,
          "ingredient": {
            "id": 280,
            "ingredient_code": 8750,
            "en_name": "MAGNESIUM SULFATE",
            "fr_name": "Sulfate de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00392618",
      "brand_name": "MAGNESIUM SULFATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "52787",
      "number_of_ais": "1",
      "ai_group_no": "0105356014"
    },
    "created_date": "2023-02-16T22:15:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00392618",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2023-07-21T00:00:00-04:00",
    "actual_start_date": "2023-02-02T00:00:00-05:00",
    "actual_end_date": "2023-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-25T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Baxter item: 5421. Product is available on allocation based on 150% of historical volumes.",
    "fr_comments": "Item Baxter: 5421. Produit disponible sous allocation, basé sur 150% du volume historique.",
    "en_drug_brand_name": "MAGNESIUM SULFATE INJ 20% USP",
    "en_drug_common_name": "MAGNESIUM",
    "fr_drug_brand_name": "MAGNESIUM SULFATE INJ 20% USP",
    "fr_drug_common_name": "MAGNESIUM",
    "en_ingredients": "MAGNESIUM SULFATE",
    "fr_ingredients": "Sulfate de magnésium",
    "drug_strength": "200MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185004,
    "drug": {
      "current_status": "MARKETED",
      "id": 9050,
      "drug_code": 61677,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253563,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238281",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2023-02-16T23:24:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238281",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-23T10:30:04-04:00",
    "status": "resolved",
    "en_comments": "250 Btl available",
    "fr_comments": "250 Btl disponible",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185007,
    "drug": {
      "current_status": "MARKETED",
      "id": 16242,
      "drug_code": 77027,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255796,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02284715",
      "brand_name": "APO-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663004"
    },
    "created_date": "2023-02-16T23:26:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284715",
    "company_name": "APOTEX INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-19T13:09:49-04:00",
    "status": "resolved",
    "en_comments": "100 bottle pack has been discontinued, 50 mg bottle pack now available",
    "fr_comments": "Le pack de 100 flacons a été abandonné, le pack de flacons de 50 mg est désormais disponible",
    "en_drug_brand_name": "APO-LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "APO-LEVOFLOXACIN",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185010,
    "drug": {
      "current_status": "MARKETED",
      "id": 16240,
      "drug_code": 77026,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255795,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02284707",
      "brand_name": "APO-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663003"
    },
    "created_date": "2023-02-16T23:27:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284707",
    "company_name": "APOTEX INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-06T16:03:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "APO-LEVOFLOXACIN",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185013,
    "drug": {
      "current_status": "MARKETED",
      "id": 16410,
      "drug_code": 77206,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255850,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286610",
      "brand_name": "APO-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928001"
    },
    "created_date": "2023-02-16T23:28:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286610",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T12:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "APO-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185019,
    "drug": {
      "current_status": "MARKETED",
      "id": 20168,
      "drug_code": 81611,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257152,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "54",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330377",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548006"
    },
    "created_date": "2023-02-16T23:31:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330377",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2023-05-19T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-12T12:51:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "54MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185022,
    "drug": {
      "current_status": "MARKETED",
      "id": 27334,
      "drug_code": 89589,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259883,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259882,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411261",
      "brand_name": "APO-AMLODIPINE-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555002"
    },
    "created_date": "2023-02-16T23:33:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411261",
    "company_name": "APOTEX INC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "estimated_end_date": "2023-02-28T00:00:00-05:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:08:44-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "en_drug_common_name": "AMLODIPINE/ATORVASTATIN",
    "fr_drug_brand_name": "APO-AMLODIPINE/ATORVASTATIN",
    "fr_drug_common_name": "AMLODIPINE/ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "AMLODIPINE/ATORVASTATIN",
    "drug_strength": "20MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185025,
    "drug": {
      "current_status": "MARKETED",
      "id": 27348,
      "drug_code": 89595,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259895,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259894,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411342",
      "brand_name": "APO-AMLODIPINE-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555008"
    },
    "created_date": "2023-02-16T23:34:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411342",
    "company_name": "APOTEX INC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "estimated_end_date": "2023-02-28T00:00:00-05:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:10:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "en_drug_common_name": "AMLODIPINE/ATORVASTATIN",
    "fr_drug_brand_name": "APO-AMLODIPINE/ATORVASTATIN",
    "fr_drug_common_name": "AMLODIPINE/ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "AMLODIPINE/ATORVASTATIN",
    "drug_strength": "80MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185028,
    "drug": {
      "current_status": "DORMANT",
      "id": 26426,
      "drug_code": 88761,
      "updated_date": "2025-12-03T02:32:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368926,
          "ingredient": {
            "id": 1498,
            "ingredient_code": 9388,
            "en_name": "ALLOPURINOL",
            "fr_name": "Allopurinol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402777",
      "brand_name": "APO-ALLOPURINOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103654002"
    },
    "created_date": "2023-02-16T23:36:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402777",
    "company_name": "APOTEX INC",
    "atc_number": "M04AA",
    "atc_description": "ANTIGOUT PREPARATIONS",
    "estimated_end_date": "2023-05-26T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-26T15:05:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALLOPURINOL",
    "en_drug_common_name": "ALLOPURINOL",
    "fr_drug_brand_name": "APO-ALLOPURINOL",
    "fr_drug_common_name": "ALLOPURINOL",
    "en_ingredients": "ALLOPURINOL",
    "fr_ingredients": "Allopurinol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185033,
    "drug": {
      "current_status": "MARKETED",
      "id": 31720,
      "drug_code": 94105,
      "updated_date": "2025-05-15T02:35:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261916,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261915,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02454475",
      "brand_name": "APO-ALENDRONATE/VITAMIN D3",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251575002"
    },
    "created_date": "2023-02-16T23:38:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02454475",
    "company_name": "APOTEX INC",
    "atc_number": "M05BB",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2023-05-14T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-21T12:29:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALENDRONATE/VITAMIN D3",
    "en_drug_common_name": "ALENDRONATE/VITAMIN D3",
    "fr_drug_brand_name": "APO-ALENDRONATE/VITAMIN D3",
    "fr_drug_common_name": "ALENDRONATE/VITAMIN D3",
    "en_ingredients": "VITAMIN D3\r\nALENDRONIC ACID",
    "fr_ingredients": "AlendronateVitamine D3",
    "drug_strength": "5600UNIT\r\n70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185036,
    "drug": {
      "current_status": "MARKETED",
      "id": 17456,
      "drug_code": 78499,
      "updated_date": "2025-12-03T00:31:15-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256148,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8256147,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02299615",
      "brand_name": "APO-DORZO-TIMOP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2023-02-16T23:40:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299615",
    "company_name": "APOTEX INC",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-23T12:14:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DORZO-TIMOP",
    "en_drug_common_name": "DORZOLAMIDE/TIMOLOL",
    "fr_drug_brand_name": "APO-DORZO/TIMOP",
    "fr_drug_common_name": "DORZOLAMIDE/TIMOLOL",
    "en_ingredients": "TIMOLOL\r\nDORZOLAMIDE",
    "fr_ingredients": "DORZOLAMIDE/TIMOLOL",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Solution\r\nSolution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185039,
    "drug": {
      "current_status": "MARKETED",
      "id": 11906,
      "drug_code": 69723,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254417,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254416,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "875",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245623",
      "brand_name": "APO-AMOXI CLAV",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720005"
    },
    "created_date": "2023-02-16T23:42:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245623",
    "company_name": "APOTEX INC",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T12:00:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMOXI CLAV",
    "en_drug_common_name": "AMOXICILLIN CLAVULANIC ACID",
    "fr_drug_brand_name": "APO-AMOXICLAV",
    "fr_drug_common_name": "AMOXICILLIN CLAVULANIC ACID",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "AMOXICILLIN CLAVULANIC ACID",
    "drug_strength": "125MG\r\n875MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185042,
    "drug": {
      "current_status": "MARKETED",
      "id": 25758,
      "drug_code": 88149,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259291,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        }
      ],
      "din": "02396467",
      "brand_name": "APO-MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676009"
    },
    "created_date": "2023-02-16T23:44:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396467",
    "company_name": "APOTEX INC",
    "estimated_end_date": "2023-05-31T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-04T19:43:00-04:00",
    "status": "resolved",
    "en_comments": "10 mL bottle available",
    "fr_comments": "10 mL disponible",
    "en_drug_brand_name": "APO-MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "APO-MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "1.5G",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "32 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185059,
    "drug": {
      "current_status": "MARKETED",
      "id": 6250,
      "drug_code": 43078,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253028,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02212188",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "P9370",
      "number_of_ais": "1",
      "ai_group_no": "0123238006"
    },
    "created_date": "2023-02-17T15:44:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212188",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2023-04-05T00:00:00-04:00",
    "actual_start_date": "2023-02-16T00:00:00-05:00",
    "actual_end_date": "2023-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-04-05T15:20:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "Sumatriptan succinate injection",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Solution injectable de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "6MG",
    "drug_dosage_form": "SOLUTION\r\nLIQUID",
    "drug_dosage_form_fr": "Solution\r\nLiquide",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "2x0.5mL (Refill pack / L’emballage de recharge)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185068,
    "drug": {
      "current_status": "MARKETED",
      "id": 54634,
      "drug_code": 95930,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262890,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "55",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470322",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548006"
    },
    "created_date": "2023-02-17T16:26:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470322",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2023-02-17T00:00:00-05:00",
    "estimated_end_date": "2023-03-28T00:00:00-04:00",
    "actual_start_date": "2023-02-17T00:00:00-05:00",
    "actual_end_date": "2023-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-03-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "55MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185077,
    "drug": {
      "current_status": "MARKETED",
      "id": 19584,
      "drug_code": 80958,
      "updated_date": "2025-05-15T02:32:21-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256831,
          "ingredient": {
            "id": 1410,
            "ingredient_code": 20259,
            "en_name": "EPIRUBICIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'épirubicine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02324091",
      "brand_name": "EPIRUBICIN FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116901002"
    },
    "created_date": "2023-02-17T17:02:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324091",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01DB",
    "atc_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
    "estimated_end_date": "2023-04-10T00:00:00-04:00",
    "actual_start_date": "2023-02-17T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "EPIRUBICIN FOR INJECTION",
    "en_drug_common_name": "EPIRUBICIN FOR INJECTION",
    "fr_drug_brand_name": "EPIRUBICIN FOR INJECTION",
    "fr_drug_common_name": "EPIRUBICIN FOR INJECTION",
    "en_ingredients": "EPIRUBICIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'épirubicine",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185082,
    "drug": {
      "current_status": "MARKETED",
      "id": 7292,
      "drug_code": 49288,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253267,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230418",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238003"
    },
    "created_date": "2023-02-17T17:11:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230418",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2023-02-24T00:00:00-05:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-23T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "Sumatriptan nasal spray",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Vaporisation nasale de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan",
    "drug_strength": "5MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "2s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185091,
    "drug": {
      "current_status": "MARKETED",
      "id": 5474,
      "drug_code": 36480,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252846,
          "ingredient": {
            "id": 304,
            "ingredient_code": 12030,
            "en_name": "DEXAMETHASONE PHOSPHATE",
            "fr_name": "Phosphate de dexaméthasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02204266",
      "brand_name": "DEXAMETHASONE-OMEGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3818",
      "number_of_ais": "1",
      "ai_group_no": "0106305003"
    },
    "created_date": "2023-02-17T21:42:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02204266",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2023-03-18T00:00:00-04:00",
    "actual_start_date": "2023-03-02T00:00:00-05:00",
    "actual_end_date": "2023-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-17T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXAMETHASONE-OMEGA",
    "en_drug_common_name": "Dexamethasone Sodium Phosphate Injection USP",
    "fr_drug_brand_name": "Dexamethasone Omega",
    "fr_drug_common_name": "Injection De Phosphate Sodique De Dexaméthasone USP",
    "en_ingredients": "DEXAMETHASONE PHOSPHATE",
    "fr_ingredients": "Phosphate de dexaméthasone",
    "drug_strength": "4MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SOFT TISSUE INJECTION\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRALESIONAL\r\nINTRA-ARTICULAR\r\nSOFT TISSUE INJECTION\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRALESIONAL\r\nINTRA-ARTICULAR",
    "drug_route_fr": "Injection dans les tissus mous\r\nIntraveineuse\r\nIntramusculaire\r\nIntralésionnelle\r\nIntra-articulaire\r\nInjection dans les tissus mous\r\nIntraveineuse\r\nIntramusculaire\r\nIntralésionnelle\r\nIntra-articulaire",
    "drug_package_quantity": "10 x 1 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185098,
    "drug": {
      "current_status": "MARKETED",
      "id": 5474,
      "drug_code": 36480,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252846,
          "ingredient": {
            "id": 304,
            "ingredient_code": 12030,
            "en_name": "DEXAMETHASONE PHOSPHATE",
            "fr_name": "Phosphate de dexaméthasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02204266",
      "brand_name": "DEXAMETHASONE-OMEGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3818",
      "number_of_ais": "1",
      "ai_group_no": "0106305003"
    },
    "created_date": "2023-02-17T21:54:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02204266",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "anticipated_start_date": "2023-03-03T00:00:00-05:00",
    "estimated_end_date": "2023-03-11T00:00:00-05:00",
    "actual_start_date": "2023-03-03T00:00:00-05:00",
    "actual_end_date": "2023-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-08T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXAMETHASONE-OMEGA",
    "en_drug_common_name": "Dexamethasone Sodium Phosphate Injection USP",
    "fr_drug_brand_name": "Dexamethasone Omega",
    "fr_drug_common_name": "Injection de Phosphate Sodique de Dexaméthasone USP",
    "en_ingredients": "DEXAMETHASONE PHOSPHATE",
    "fr_ingredients": "Phosphate de dexaméthasone",
    "drug_strength": "4MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SOFT TISSUE INJECTION\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRALESIONAL\r\nINTRA-ARTICULAR\r\nSOFT TISSUE INJECTION\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRALESIONAL\r\nINTRA-ARTICULAR",
    "drug_route_fr": "Injection dans les tissus mous\r\nIntraveineuse\r\nIntramusculaire\r\nIntralésionnelle\r\nIntra-articulaire\r\nInjection dans les tissus mous\r\nIntraveineuse\r\nIntramusculaire\r\nIntralésionnelle\r\nIntra-articulaire",
    "drug_package_quantity": "10 x 25 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185103,
    "drug": {
      "current_status": "MARKETED",
      "id": 10806,
      "drug_code": 66636,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254083,
          "ingredient": {
            "id": 2312,
            "ingredient_code": 9011,
            "en_name": "SCOPOLAMINE HYDROBROMIDE",
            "fr_name": "Bromhydrate de scopolamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242811",
      "brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104674004"
    },
    "created_date": "2023-02-17T22:02:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242811",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "N05CM",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2023-02-27T00:00:00-05:00",
    "estimated_end_date": "2023-03-06T00:00:00-05:00",
    "actual_end_date": "2023-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-24T17:42:57-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
    "en_drug_common_name": "Scopolamine Hydrobromide Injection",
    "fr_drug_brand_name": "Injection De Bromhydrate De Scopolamine",
    "fr_drug_common_name": "Injection De Bromhydrate De Scopolamine",
    "en_ingredients": "SCOPOLAMINE HYDROBROMIDE",
    "fr_ingredients": "Bromhydrate de scopolamine",
    "drug_strength": "0.6MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1 mL vial / fiole",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185130,
    "drug": {
      "current_status": "MARKETED",
      "id": 100792,
      "drug_code": 99186,
      "updated_date": "2020-08-04T23:50:48-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265408,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02502283",
      "brand_name": "M-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2023-02-20T12:15:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02502283",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2023-02-28T00:00:00-05:00",
    "actual_start_date": "2023-02-13T00:00:00-05:00",
    "actual_end_date": "2023-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-03-06T12:48:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-CLOPIDOGREL",
    "en_drug_common_name": "Clopidogrel",
    "fr_drug_brand_name": "M-Clopidogrel",
    "fr_drug_common_name": "Clopidogrel",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "Clopidogrel",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185133,
    "drug": {
      "current_status": "MARKETED",
      "id": 55918,
      "drug_code": 96041,
      "updated_date": "2025-05-15T02:36:14-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262969,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471302",
      "brand_name": "M-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294005"
    },
    "created_date": "2023-02-20T12:22:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02471302",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-11-30T00:00:00-05:00",
    "actual_start_date": "2023-01-16T00:00:00-05:00",
    "actual_end_date": "2023-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-12-04T14:42:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-VENLAFAXINE XR",
    "en_drug_common_name": "M-Venlafaxine XR",
    "fr_drug_brand_name": "M-Venlafaxine XR",
    "fr_drug_common_name": "M-Venlafaxine xr",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine XR",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185181,
    "drug": {
      "current_status": "MARKETED",
      "id": 7368,
      "drug_code": 49702,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8253291,
          "ingredient": {
            "id": 256,
            "ingredient_code": 10010,
            "en_name": "NEOSTIGMINE METHYLSULFATE",
            "fr_name": "Méthylsulfate de néostigmine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02230593",
      "brand_name": "NEOSTIGMINE OMEGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102263002"
    },
    "created_date": "2023-02-20T16:40:39-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02230593",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "N07AA",
    "atc_description": "PARASYMPATHOMIMETICS",
    "discontinuation_date": "2023-02-20T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Product is not available.",
    "fr_supply_disruption_mitigation": "Le produit n’est pas disponible.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-02-21T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "NEOSTIGMINE OMEGA",
    "en_drug_common_name": "Neostigmine Methylsulfate Injection USP",
    "fr_drug_brand_name": "Neostigmine Omega",
    "fr_drug_common_name": "Injection De Méthylsulfate De Néostigmine USP",
    "en_ingredients": "NEOSTIGMINE METHYLSULFATE",
    "fr_ingredients": "Méthylsulfate de néostigmine",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1mL vial / fiole",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185233,
    "drug": {
      "current_status": "MARKETED",
      "id": 8812,
      "drug_code": 60939,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253530,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237600",
      "brand_name": "PMS-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2023-02-21T16:29:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237600",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2023-06-21T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-06-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-26T19:28:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "pms-ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30,100,500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185238,
    "drug": {
      "current_status": "MARKETED",
      "id": 17790,
      "drug_code": 78850,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256249,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303175",
      "brand_name": "PMS-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2023-02-21T16:45:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303175",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2023-07-20T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-08-07T14:25:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "pms-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185263,
    "drug": {
      "current_status": "MARKETED",
      "id": 12822,
      "drug_code": 71882,
      "updated_date": "2025-05-15T02:31:26-04:00",
      "company": {
        "id": 140,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 4835,
        "mfr_code": "ODN07",
        "name": "ODAN LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "325 STILLVIEW AVENUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 2Y6",
        "post_office_box": "",
        "contact_information": "info@odanlab.com\r\nTel.: 1-800-387-9342\r\nFax: 1-800-329-6326"
      },
      "drug_ingredients": [
        {
          "id": 8254682,
          "ingredient": {
            "id": 294,
            "ingredient_code": 10068,
            "en_name": "CHLORAL HYDRATE",
            "fr_name": "Hydrate de chloral"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02247621",
      "brand_name": "CHLORAL HYDRATE SYRUP ODAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101992002"
    },
    "created_date": "2023-02-21T19:50:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247621",
    "company_name": "ODAN LABORATORIES LTD",
    "atc_number": "N05CC",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-27T13:18:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CHLORAL HYDRATE SYRUP ODAN",
    "en_drug_common_name": "Chloral Hydrate Oral Solution",
    "fr_drug_brand_name": "Chloral Hydrate Sirop Odan",
    "fr_drug_common_name": "Solution orale d'hydrate de chloral",
    "en_ingredients": "CHLORAL HYDRATE",
    "fr_ingredients": "Hydrate de chloral",
    "drug_strength": "500MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185280,
    "drug": {
      "current_status": "MARKETED",
      "id": 2044,
      "drug_code": 14322,
      "updated_date": "2025-12-03T00:30:31-05:00",
      "company": {
        "id": 17224,
        "created_date": "2022-08-08T04:00:11-04:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 18632,
        "mfr_code": "",
        "name": "KARO PHARMA AB",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "KLARA NORRA KYRKOGATA 33",
        "province": "--",
        "country": "SWEDEN",
        "city": "STOCKHOLM",
        "postal_code": "11122",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251945,
          "ingredient": {
            "id": 1064,
            "ingredient_code": 1374,
            "en_name": "BUMETANIDE",
            "fr_name": "Bumétanide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00728276",
      "brand_name": "BURINEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75899",
      "number_of_ais": "1",
      "ai_group_no": "0119025001"
    },
    "created_date": "2023-02-22T16:29:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00728276",
    "company_name": "KARO PHARMA AB",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "actual_start_date": "2022-12-05T00:00:00-05:00",
    "actual_end_date": "2023-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-04-24T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BURINEX",
    "en_drug_common_name": "BURINEX TAB 5 MG",
    "fr_drug_brand_name": "BURINEX",
    "fr_drug_common_name": "Burinex 5mg",
    "en_ingredients": "BUMETANIDE",
    "fr_ingredients": "Bumétanide",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185300,
    "drug": {
      "current_status": "MARKETED",
      "id": 102495,
      "drug_code": 99442,
      "updated_date": "2021-12-08T06:08:06-05:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265589,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8265588,
          "ingredient": {
            "id": 1632,
            "ingredient_code": 224,
            "en_name": "ADAPALENE",
            "fr_name": "Adapalène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02505053",
      "brand_name": "TARO-ADAPALENE/BENZOYL PEROXIDE FORTE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252888002"
    },
    "created_date": "2023-02-22T21:09:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02505053",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "actual_start_date": "2023-01-16T00:00:00-05:00",
    "actual_end_date": "2023-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-08-16T18:44:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-ADAPALENE/BENZOYL PEROXIDE FORTE",
    "en_drug_common_name": "ADAPALENE/BENZOYL",
    "fr_drug_brand_name": "TARO-ADAPALENE/BENZOYL PEROXIDE FORTE",
    "fr_drug_common_name": "ADAPALINE/BENZOYL",
    "en_ingredients": "BENZOYL PEROXIDE\r\nADAPALENE",
    "fr_ingredients": "Peroxyde de benzoyle\r\nAdapalène",
    "drug_strength": "2.5%\r\n0.3%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "70g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185303,
    "drug": {
      "current_status": "MARKETED",
      "id": 51759,
      "drug_code": 95265,
      "updated_date": "2025-05-15T02:35:52-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262531,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8262530,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02464519",
      "brand_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561001"
    },
    "created_date": "2023-02-22T21:11:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464519",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "actual_start_date": "2023-02-10T00:00:00-05:00",
    "actual_end_date": "2023-11-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-05T16:00:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
    "en_drug_common_name": "BENZO/CLINDA",
    "fr_drug_brand_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
    "fr_drug_common_name": "BENZO/CLINDA",
    "en_ingredients": "BENZOYL PEROXIDE\r\nCLINDAMYCIN",
    "fr_ingredients": "Peroxyde de benzoyle",
    "drug_strength": "5%\r\n1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "50g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185326,
    "drug": {
      "current_status": "MARKETED",
      "id": 14848,
      "drug_code": 75233,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255323,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02266938",
      "brand_name": "TARO-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830004"
    },
    "created_date": "2023-02-22T21:25:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02266938",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2023-07-21T00:00:00-04:00",
    "actual_start_date": "2023-02-16T00:00:00-05:00",
    "actual_end_date": "2023-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-08-16T18:59:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLINDAMYCIN",
    "en_drug_common_name": "CLINDAMYCIN",
    "fr_drug_brand_name": "TARO-CLINDAMYCIN",
    "fr_drug_common_name": "CLINDAMYCIN",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCIN",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185335,
    "drug": {
      "current_status": "MARKETED",
      "id": 11864,
      "drug_code": 69609,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254397,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245522",
      "brand_name": "TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2023-02-22T21:27:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245522",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2023-04-28T00:00:00-04:00",
    "actual_start_date": "2023-02-14T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T18:17:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185338,
    "drug": {
      "current_status": "MARKETED",
      "id": 5146,
      "drug_code": 31491,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252793,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02142546",
      "brand_name": "STERILE WATER FOR INJECTION USP",
      "brand_name_fr": "EAU STÉRILE POUR PRÉPARATIONS INJECTABLES USP",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "F8788",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2023-02-22T21:28:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02142546",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "actual_start_date": "2023-04-12T00:00:00-04:00",
    "actual_end_date": "2024-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-07-04T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STERILE WATER FOR INJECTION USP",
    "en_drug_common_name": "STERILE WATER FOR INJECTION USP",
    "fr_drug_brand_name": "Eau stérile pour préparations injectables USP",
    "fr_drug_common_name": "Eau stérile pour préparations injectables USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAPERITONEAL\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAPERITONEAL\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntrapéritonéale\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntrapéritonéale\r\nIntramusculaire",
    "drug_package_quantity": "25 x 20mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185423,
    "drug": {
      "current_status": "MARKETED",
      "id": 7390,
      "drug_code": 49895,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8253295,
          "ingredient": {
            "id": 198,
            "ingredient_code": 7581,
            "en_name": "BUDESONIDE",
            "fr_name": "Budésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230648",
      "brand_name": "MYLAN-BUDESONIDE AQ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116807002"
    },
    "created_date": "2023-02-23T13:25:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230648",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2025-04-17T00:00:00-04:00",
    "actual_start_date": "2022-07-03T00:00:00-04:00",
    "actual_end_date": "2025-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-23T12:15:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-BUDESONIDE AQ",
    "en_drug_common_name": "BUDESONIDE",
    "fr_drug_brand_name": "MYLAN-BUDESONIDE AQ",
    "fr_drug_common_name": "BUDESONIDE",
    "en_ingredients": "BUDESONIDE",
    "fr_ingredients": "Budésonide",
    "drug_strength": "100MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "165 DOSE",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185448,
    "drug": {
      "current_status": "MARKETED",
      "id": 3074,
      "drug_code": 17827,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252220,
          "ingredient": {
            "id": 598,
            "ingredient_code": 11162,
            "en_name": "ACEBUTOLOL",
            "fr_name": "Acébutolol (Chlorhydrate d'acébutolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02147610",
      "brand_name": "APO-ACEBUTOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80034",
      "number_of_ais": "1",
      "ai_group_no": "0131282003"
    },
    "created_date": "2023-02-23T14:11:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02147610",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2023-03-17T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T11:49:28-04:00",
    "status": "resolved",
    "en_comments": "100 Btl available",
    "en_drug_brand_name": "APO-ACEBUTOLOL",
    "en_drug_common_name": "ACEBUTOLOL",
    "fr_drug_brand_name": "APO-ACEBUTOLOL",
    "fr_drug_common_name": "ACEBUTOLOL",
    "en_ingredients": "ACEBUTOLOL",
    "fr_ingredients": "Acebutolol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185451,
    "drug": {
      "current_status": "MARKETED",
      "id": 9924,
      "drug_code": 64160,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253789,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "TAB",
          "base": false
        }
      ],
      "din": "02240589",
      "brand_name": "APO-DOXAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131431003"
    },
    "created_date": "2023-02-23T14:12:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240589",
    "company_name": "APOTEX INC",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-23T10:27:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOXAZOSIN",
    "en_drug_common_name": "DOXAZOSIN",
    "fr_drug_brand_name": "APO-DOXAZOSIN",
    "fr_drug_common_name": "DOXAZOSIN",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "Doxazosin",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185456,
    "drug": {
      "current_status": "MARKETED",
      "id": 4134,
      "drug_code": 19962,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252587,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216353",
      "brand_name": "APO-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82261",
      "number_of_ais": "1",
      "ai_group_no": "0116847003"
    },
    "created_date": "2023-02-23T14:14:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216353",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-22T00:00:00-05:00",
    "actual_end_date": "2023-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:05:18-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE",
    "fr_drug_brand_name": "APO-FLUOXETINE",
    "fr_drug_common_name": "FLUOXETINE",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "Fluoxetine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185459,
    "drug": {
      "current_status": "MARKETED",
      "id": 8016,
      "drug_code": 5222,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250723,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00592277",
      "brand_name": "APO-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60000",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2023-02-23T14:15:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00592277",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2023-05-05T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-06T15:59:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185462,
    "drug": {
      "current_status": "MARKETED",
      "id": 26,
      "drug_code": 10034,
      "updated_date": "2025-12-03T00:30:29-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251274,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00782483",
      "brand_name": "AA-VERAP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69679",
      "number_of_ais": "1",
      "ai_group_no": "0113846002"
    },
    "created_date": "2023-02-23T14:17:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00782483",
    "company_name": "APOTEX INC",
    "atc_number": "C08DA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:14:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VERAP TAB 80MG",
    "en_drug_common_name": "VERAPAMIL",
    "fr_drug_brand_name": "APO-VERAP",
    "fr_drug_common_name": "VERAPAMIL",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185465,
    "drug": {
      "current_status": "MARKETED",
      "id": 16814,
      "drug_code": 77773,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255941,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292386",
      "brand_name": "APO-PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169002"
    },
    "created_date": "2023-02-23T14:18:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292386",
    "company_name": "APOTEX INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2023-04-14T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-14T16:23:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "APO-PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185468,
    "drug": {
      "current_status": "MARKETED",
      "id": 19790,
      "drug_code": 81129,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256912,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02325942",
      "brand_name": "APO-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663005"
    },
    "created_date": "2023-02-23T14:19:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325942",
    "company_name": "APOTEX INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-06T16:03:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "APO-LEVOFLOXACIN",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185471,
    "drug": {
      "current_status": "MARKETED",
      "id": 28212,
      "drug_code": 90348,
      "updated_date": "2025-05-15T02:34:11-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260238,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02418940",
      "brand_name": "APO-CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043002"
    },
    "created_date": "2023-02-23T14:20:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418940",
    "company_name": "APOTEX INC",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:16:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CELECOXIB",
    "en_drug_common_name": "CELECOXIB",
    "fr_drug_brand_name": "APO-CELECOXIB",
    "fr_drug_common_name": "CELECOXIB",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185474,
    "drug": {
      "current_status": "MARKETED",
      "id": 62320,
      "drug_code": 93078,
      "updated_date": "2025-12-03T00:32:54-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261426,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445506",
      "brand_name": "APO-AMPHETAMINE XR",
      "brand_name_fr": "APO-AMPHÉTAMINE XR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310002"
    },
    "created_date": "2023-02-23T14:22:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445506",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-23T10:22:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE",
    "fr_drug_brand_name": "APO-AMPHETAMINE",
    "fr_drug_common_name": "AMPHETAMINE",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "Amphetamine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185477,
    "drug": {
      "current_status": "MARKETED",
      "id": 56388,
      "drug_code": 96021,
      "updated_date": "2025-05-15T02:36:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262952,
          "ingredient": {
            "id": 3528,
            "ingredient_code": 20435,
            "en_name": "ARIPIPRAZOLE",
            "fr_name": "Aripiprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471108",
      "brand_name": "APO-ARIPIPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152514006"
    },
    "created_date": "2023-02-23T14:23:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02471108",
    "company_name": "APOTEX INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T12:02:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ARIPIPRAZOLE",
    "en_drug_common_name": "ARIPIPRAZOLE",
    "fr_drug_brand_name": "APO-ARIPIPRAZOLE",
    "fr_drug_common_name": "ARIPIPRAZOLE",
    "en_ingredients": "ARIPIPRAZOLE",
    "fr_ingredients": "Aripiprazole",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185480,
    "drug": {
      "current_status": "MARKETED",
      "id": 29674,
      "drug_code": 9170,
      "updated_date": "2025-05-15T02:30:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251123,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00768715",
      "brand_name": "APO-CEPHALEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68040",
      "number_of_ais": "1",
      "ai_group_no": "0105911003"
    },
    "created_date": "2023-02-23T14:25:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00768715",
    "company_name": "APOTEX INC",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:28:03-05:00",
    "status": "resolved",
    "en_comments": "500 Btl available",
    "fr_comments": "500 btl disponible",
    "en_drug_brand_name": "APO-CEPHALEX",
    "en_drug_common_name": "CEPHALEXIN",
    "fr_drug_brand_name": "APO-CEPHALEX",
    "fr_drug_common_name": "CEPHALEXIN",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185483,
    "drug": {
      "current_status": "MARKETED",
      "id": 11090,
      "drug_code": 67257,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254165,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254164,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243350",
      "brand_name": "APO-AMOXI CLAV",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720008"
    },
    "created_date": "2023-02-23T14:26:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243350",
    "company_name": "APOTEX INC",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T12:01:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMOXI CLAV",
    "en_drug_common_name": "AMOXICILLIN CLAVULANIC ACID",
    "fr_drug_brand_name": "APO-AMOXICLAV",
    "fr_drug_common_name": "AMOXICILLIN CLAVULANIC ACID",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "125MG\r\n250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185486,
    "drug": {
      "current_status": "MARKETED",
      "id": 102908,
      "drug_code": 101564,
      "updated_date": "2022-05-08T05:14:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8267085,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02526557",
      "brand_name": "APO-FLUTICASONE HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685004"
    },
    "created_date": "2023-02-23T14:28:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02526557",
    "company_name": "APOTEX INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:17:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUTICASONE HFA",
    "en_drug_common_name": "FLUTICASONE",
    "fr_drug_brand_name": "APO-FLUTICASONE HFA",
    "fr_drug_common_name": "FLUTICASONE",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "125MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "ORAL\r\nINHALATION",
    "drug_route_fr": "Orale\r\nInhalation",
    "drug_package_quantity": "120 MD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185489,
    "drug": {
      "current_status": "MARKETED",
      "id": 11166,
      "drug_code": 67457,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254195,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243539",
      "brand_name": "APO-LABETALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116170003"
    },
    "created_date": "2023-02-23T14:29:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243539",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2023-03-03T00:00:00-05:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-02T13:17:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LABETALOL",
    "en_drug_common_name": "LABETALOL",
    "fr_drug_brand_name": "APO-LABETALOL",
    "fr_drug_common_name": "LABETALOL",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185492,
    "drug": {
      "current_status": "MARKETED",
      "id": 61188,
      "drug_code": 95756,
      "updated_date": "2025-12-03T00:33:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262795,
          "ingredient": {
            "id": 3466,
            "ingredient_code": 20301,
            "en_name": "DABIGATRAN ETEXILATE",
            "fr_name": "Dabigatran étexilate (Mésilate de dabigatran étexilate)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468913",
      "brand_name": "APO-DABIGATRAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152467003"
    },
    "created_date": "2023-02-23T14:31:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468913",
    "company_name": "APOTEX INC",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2023-03-24T00:00:00-04:00",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-23T10:24:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DABIGATRAN",
    "en_drug_common_name": "DABIGATRAN",
    "fr_drug_brand_name": "APO-DABIGATRAN",
    "fr_drug_common_name": "DABIGATRAN",
    "en_ingredients": "DABIGATRAN ETEXILATE",
    "fr_ingredients": "Dabigatran",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185509,
    "drug": {
      "current_status": "MARKETED",
      "id": 1010,
      "drug_code": 1239,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250249,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037826",
      "brand_name": "SODIUM CHLORIDE IRRIGATION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "37933",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2023-02-23T17:37:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037826",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2023-03-21T00:00:00-04:00",
    "estimated_end_date": "2023-04-07T00:00:00-04:00",
    "actual_end_date": "2023-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-14T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE IRRIGATION USP",
    "en_drug_common_name": "Sodium Chloride Irrigation USP",
    "fr_drug_brand_name": "Chlorure de sodium à irrigation USP",
    "fr_drug_common_name": "Chlorure de sodium à irrigation USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "IRRIGATION\r\nINTRAPERITONEAL\r\nINTRAPERITONEAL\r\nIRRIGATION",
    "drug_route_fr": "Irrigation\r\nIntrapéritonéale\r\nIntrapéritonéale\r\nIrrigation",
    "drug_package_quantity": "3000 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185520,
    "drug": {
      "current_status": "MARKETED",
      "id": 9892,
      "drug_code": 64089,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253779,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02240518",
      "brand_name": "MAXALT RPD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841001"
    },
    "created_date": "2023-02-23T19:43:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240518",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2023-05-26T00:00:00-04:00",
    "actual_start_date": "2023-02-23T00:00:00-05:00",
    "actual_end_date": "2023-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-05-27T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAXALT RPD",
    "en_drug_common_name": "rizatriptan benzoate wafers",
    "fr_drug_brand_name": "MAXALT RPD",
    "fr_drug_common_name": "cachets ultra-fondants de benzoate de rizatriptan",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "rizatriptan",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "12",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185528,
    "drug": {
      "current_status": "MARKETED",
      "id": 100441,
      "drug_code": 98805,
      "updated_date": "2020-06-16T22:21:14-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8265008,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02498278",
      "brand_name": "MORPHINE SULFATE INJECTION EPIDURAL",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545007"
    },
    "created_date": "2023-02-23T21:00:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02498278",
    "company_name": "STERIMAX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2023-05-19T00:00:00-04:00",
    "actual_start_date": "2023-02-20T00:00:00-05:00",
    "actual_end_date": "2023-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-05-23T12:53:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MORPHINE SULFATE INJECTION EPIDURAL",
    "en_drug_common_name": "MORPHINE SULFATE INJECTION EPIDURAL",
    "fr_drug_brand_name": "SULFATE DE MORPHINE INJECTION ÉPIDURALE",
    "fr_drug_common_name": "SULFATE DE MORPHINE INJECTION ÉPIDURALE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL",
    "drug_route_fr": "Épidurale",
    "drug_package_quantity": "0.5 MG/ML  10 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185563,
    "drug": {
      "current_status": "MARKETED",
      "id": 3236,
      "drug_code": 18243,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252282,
          "ingredient": {
            "id": 212,
            "ingredient_code": 8632,
            "en_name": "GENTAMICIN",
            "fr_name": "Gentamicine (Sulfate de gentamicine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02082152",
      "brand_name": "GENTAMICIN(E)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80466",
      "number_of_ais": "1",
      "ai_group_no": "0105695010"
    },
    "created_date": "2023-02-24T19:36:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02082152",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "anticipated_start_date": "2023-02-24T00:00:00-05:00",
    "estimated_end_date": "2023-03-27T00:00:00-04:00",
    "actual_start_date": "2023-02-24T00:00:00-05:00",
    "actual_end_date": "2023-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-28T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Baxter product Gentamicin Sulfate Injection in 0.9% Sodium Chloride Injection 1 mg / mL (100 mg / 100 mL) (JB0863) is available as a substitute if aligned with clinical practice.",
    "fr_comments": "Le produit Baxter Sulfate de gentamicine injectable dans du chlorure de sodium à 0,9 % injectable 1 mg / mL (100 mg / 100 mL) (JB0863) est disponible comme substitut s'il est conforme à la pratique clinique.",
    "en_drug_brand_name": "GENTAMICIN(E)",
    "en_drug_common_name": "GENTAMICIN(E)",
    "fr_drug_brand_name": "GENTAMICIN(E)",
    "fr_drug_common_name": "GENTAMICIN(E)",
    "en_ingredients": "GENTAMICIN",
    "fr_ingredients": "Gentamicine",
    "drug_strength": "1.6MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "80mg/50mL (JB0852P)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185581,
    "drug": {
      "current_status": "MARKETED",
      "id": 62763,
      "drug_code": 92331,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261057,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02438933",
      "brand_name": "ACH-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2023-02-24T21:28:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438933",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2023-02-24T00:00:00-05:00",
    "actual_end_date": "2023-03-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-03-10T21:05:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ACH-Rosuvastatine",
    "fr_drug_common_name": "ROSUVASTATINE",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185586,
    "drug": {
      "current_status": "MARKETED",
      "id": 98905,
      "drug_code": 94320,
      "updated_date": "2020-04-03T06:53:11-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8262030,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456338",
      "brand_name": "ACH-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496003"
    },
    "created_date": "2023-02-24T21:29:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456338",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-07T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN MEDOXOMIL",
    "fr_drug_brand_name": "ACH-Olmesartan",
    "fr_drug_common_name": "OLMESARTAN MEDOXOMIL",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "OLMESARTAN MEDOXOMIL",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185589,
    "drug": {
      "current_status": "MARKETED",
      "id": 66077,
      "drug_code": 92501,
      "updated_date": "2025-05-15T02:34:46-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261123,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440644",
      "brand_name": "ACH-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2023-02-24T21:31:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440644",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2023-02-21T00:00:00-05:00",
    "actual_end_date": "2023-03-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-18T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "ACH Pravastatine",
    "fr_drug_common_name": "Pravastatine",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185592,
    "drug": {
      "current_status": "MARKETED",
      "id": 24788,
      "drug_code": 87340,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258951,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387824",
      "brand_name": "ACH-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2023-02-24T21:33:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387824",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2023-08-31T00:00:00-04:00",
    "actual_start_date": "2023-02-24T00:00:00-05:00",
    "actual_end_date": "2023-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-09-01T18:16:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE TABLETS",
    "en_drug_common_name": "QUETIAPINE FUMARATE",
    "fr_drug_brand_name": "ACH Quetiapine",
    "fr_drug_common_name": "Quétiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Fumarate de quétiapine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185595,
    "drug": {
      "current_status": "MARKETED",
      "id": 23852,
      "drug_code": 86516,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258584,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379287",
      "brand_name": "ACH-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2023-02-24T21:35:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379287",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2023-02-24T00:00:00-05:00",
    "actual_end_date": "2023-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-04-28T16:44:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN CILEXETIL",
    "fr_drug_brand_name": "ACH-CANDESARTAN",
    "fr_drug_common_name": "Candésartan cilexétil",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185598,
    "drug": {
      "current_status": "MARKETED",
      "id": 25688,
      "drug_code": 88080,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8259283,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395746",
      "brand_name": "ACH-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938002"
    },
    "created_date": "2023-02-24T21:37:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395746",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2023-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-20T18:25:25-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "ACH-TOPIRAMATE",
    "fr_drug_common_name": "Topiramate",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185609,
    "drug": {
      "current_status": "MARKETED",
      "id": 64740,
      "drug_code": 98031,
      "updated_date": "2025-12-03T00:34:29-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264238,
          "ingredient": {
            "id": 3532,
            "ingredient_code": 20437,
            "en_name": "LISDEXAMFETAMINE DIMESYLATE",
            "fr_name": "Dimésylate de lisdexamfétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02490250",
      "brand_name": "VYVANSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152536004"
    },
    "created_date": "2023-02-25T00:19:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02490250",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2023-02-24T00:00:00-05:00",
    "estimated_end_date": "2023-03-17T00:00:00-04:00",
    "actual_start_date": "2023-02-24T00:00:00-05:00",
    "actual_end_date": "2023-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-03-07T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VYVANSE",
    "en_drug_common_name": "Lisdexamfetamine dimesylate chewable tablets",
    "fr_drug_brand_name": "VYVANSE",
    "fr_drug_common_name": "Lisdexamfetamine dimesylate chewable tablets",
    "en_ingredients": "LISDEXAMFETAMINE DIMESYLATE",
    "fr_ingredients": "Dimésylate de lisdexamfétamine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185638,
    "drug": {
      "current_status": "MARKETED",
      "id": 9406,
      "drug_code": 62666,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253667,
          "ingredient": {
            "id": 1970,
            "ingredient_code": 7897,
            "en_name": "RUBELLA VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin antirubéoleux vivant atténué (souche wistar ra27/3)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253666,
          "ingredient": {
            "id": 1972,
            "ingredient_code": 7908,
            "en_name": "MEASLES VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin antirougeoleux, vivant, atténué"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253665,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "ML",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8253664,
          "ingredient": {
            "id": 1968,
            "ingredient_code": 11271,
            "en_name": "MUMPS VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin contre les oreillons vivant atténué (souche jeryl lynn)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02239208",
      "brand_name": "PRIORIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0431514004"
    },
    "created_date": "2023-02-27T20:12:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239208",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BD",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2023-03-17T00:00:00-04:00",
    "actual_start_date": "2023-02-22T00:00:00-05:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-16T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Limited supply available for public programs. Supply unavailable for the private market.",
    "fr_comments": "Approvisionnement limité réservé aux programmes publics d’immunisation. Aucun approvisionnement disponible pour le marché privé.",
    "en_drug_brand_name": "PRIORIX",
    "en_drug_common_name": "Combined measles, mumps and rubella vaccine, live, attenuated",
    "fr_drug_brand_name": "PRIORIX",
    "fr_drug_common_name": "Vaccin associé rougeole-oreillons-rubéole à virus vivants, atténués",
    "en_ingredients": "WATER\r\nRUBELLA VIRUS VACCINE LIVE ATTENUATED\r\nMEASLES VIRUS VACCINE LIVE ATTENUATED\r\nMUMPS VIRUS VACCINE LIVE ATTENUATED",
    "fr_ingredients": "Eau;\r\nVaccin antirougeoleux, vivant, atténué;\r\nVaccin contre les oreillons vivant atténué (souche jeryl lynn);  \r\nVaccin antirubéoleux vivant atténué (souche wistar ra27/3)",
    "drug_strength": "0.5ML\r\n1000CCID50\r\n1000CCID50\r\n10000CCID50",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nIntramusculaire\r\nSous-cutanée",
    "drug_package_quantity": "10s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185649,
    "drug": {
      "current_status": "MARKETED",
      "id": 3410,
      "drug_code": 18640,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252346,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02168898",
      "brand_name": "ESTRING",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80910",
      "number_of_ais": "1",
      "ai_group_no": "0106457001"
    },
    "created_date": "2023-02-27T22:37:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02168898",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "anticipated_start_date": "2023-03-15T00:00:00-04:00",
    "estimated_end_date": "2023-05-02T00:00:00-04:00",
    "actual_start_date": "2023-03-13T00:00:00-04:00",
    "actual_end_date": "2023-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-09T15:54:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTRING",
    "en_drug_common_name": "ESTRING",
    "fr_drug_brand_name": "ESTRING",
    "fr_drug_common_name": "ESTRING",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "2MG",
    "drug_dosage_form": "RING (SLOW-RELEASE)",
    "drug_dosage_form_fr": "Anneau (à libération lente)",
    "drug_route": "VAGINAL\r\nVAGINAL",
    "drug_route_fr": "Vaginale\r\nVaginale",
    "drug_package_quantity": "1 ea",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185659,
    "drug": {
      "current_status": "MARKETED",
      "id": 19800,
      "drug_code": 81134,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 1080,
        "created_date": "2017-03-09T13:23:42-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 3652,
        "mfr_code": "",
        "name": "DENTSPLY CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1",
        "street_name": "525 ROWNTREE DAIRY ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 7K6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256915,
          "ingredient": {
            "id": 444,
            "ingredient_code": 9471,
            "en_name": "LIDOCAINE",
            "fr_name": "Lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256914,
          "ingredient": {
            "id": 442,
            "ingredient_code": 5776,
            "en_name": "PRILOCAINE",
            "fr_name": "Prilocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325993",
      "brand_name": "ORAQIX",
      "brand_name_fr": "",
      "descriptor": "FOR PERIODONTAL USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0222447001"
    },
    "created_date": "2023-02-28T14:47:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325993",
    "company_name": "DENTSPLY CANADA LIMITED",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2023-02-23T00:00:00-05:00",
    "estimated_end_date": "2023-04-23T00:00:00-04:00",
    "actual_start_date": "2023-02-23T00:00:00-05:00",
    "actual_end_date": "2023-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-04-26T16:18:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ORAQIX",
    "en_drug_common_name": "LIDOCAINE 2.5%/ PRILOCAINE 2.5%",
    "fr_drug_brand_name": "ORAQIX",
    "fr_drug_common_name": "LIDOCAINE 2.5%/ PRILOCAINE 2.5%",
    "en_ingredients": "LIDOCAINE\r\nPRILOCAINE",
    "fr_ingredients": "Lidocaïne\r\nPrilocaïne",
    "drug_strength": "2.5%\r\n2.5%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "20 x 1.7 g Cartridges",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185664,
    "drug": {
      "current_status": "MARKETED",
      "id": 21980,
      "drug_code": 84336,
      "updated_date": "2025-12-03T00:31:41-05:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8257863,
          "ingredient": {
            "id": 2328,
            "ingredient_code": 6299,
            "en_name": "ACETAZOLAMIDE",
            "fr_name": "Acétazolamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02358328",
      "brand_name": "ACETAZOLAMIDE FOR INJECTION, USP",
      "brand_name_fr": "ACÉTAZOLAMIDE POUR INJECTION, USP",
      "descriptor": "SINGLE UNIT VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107512002"
    },
    "created_date": "2023-02-28T14:57:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02358328",
    "company_name": "STERIMAX INC",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2023-03-06T00:00:00-05:00",
    "actual_start_date": "2023-02-28T00:00:00-05:00",
    "actual_end_date": "2023-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-03T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAZOLAMIDE FOR INJECTION, USP",
    "en_drug_common_name": "ACETAZOLAMIDE FOR INJECTION, USP",
    "fr_drug_brand_name": "ACÉTAZOLAMIDE POUR INJECTION USP",
    "fr_drug_common_name": "ACÉTAZOLAMIDE POUR INJECTION USP",
    "en_ingredients": "ACETAZOLAMIDE",
    "fr_ingredients": "Acétazolamide",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185677,
    "drug": {
      "current_status": "MARKETED",
      "id": 3816,
      "drug_code": 19315,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252482,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02162423",
      "brand_name": "NAPROSYN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81607",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2023-02-28T17:50:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02162423",
    "company_name": "ATNAHS PHARMA UK LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2025-10-31T00:00:00-04:00",
    "actual_start_date": "2023-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-07-08T15:05:29-04:00",
    "status": "active_confirmed",
    "en_comments": "Product now Out of stock again due to increased demand",
    "en_drug_brand_name": "NAPROSYN",
    "en_drug_common_name": "Naprosyn Tabs",
    "fr_drug_brand_name": "Naprosyn",
    "fr_drug_common_name": "Naproxen",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185682,
    "drug": {
      "current_status": "MARKETED",
      "id": 27296,
      "drug_code": 89542,
      "updated_date": "2025-05-15T02:34:01-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259865,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410753",
      "brand_name": "LORAZEPAM SUBLINGUAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110731001"
    },
    "created_date": "2023-02-28T18:07:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410753",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2023-02-28T00:00:00-05:00",
    "estimated_end_date": "2023-04-25T00:00:00-04:00",
    "actual_end_date": "2023-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-01T15:46:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LORAZEPAM SUBLINGUAL",
    "en_drug_common_name": "Lorazepam SBL",
    "fr_drug_brand_name": "Lorazepam Sublingual",
    "fr_drug_common_name": "Lorazepam Sublingual",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185687,
    "drug": {
      "current_status": "MARKETED",
      "id": 9944,
      "drug_code": 6421,
      "updated_date": "2025-12-03T00:30:23-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250893,
          "ingredient": {
            "id": 1816,
            "ingredient_code": 8426,
            "en_name": "PENICILLIN V POTASSIUM",
            "fr_name": "Pénicilline v potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00642215",
      "brand_name": "PEN-VK",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63031",
      "number_of_ais": "1",
      "ai_group_no": "0105897011"
    },
    "created_date": "2023-02-28T18:18:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00642215",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01CE",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "anticipated_start_date": "2023-02-28T00:00:00-05:00",
    "estimated_end_date": "2023-05-19T00:00:00-04:00",
    "actual_end_date": "2023-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-13T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PEN-VK",
    "en_drug_common_name": "PEN-VK",
    "fr_drug_brand_name": "PEN-VK",
    "fr_drug_common_name": "PEN-VK",
    "en_ingredients": "PENICILLIN V POTASSIUM",
    "fr_ingredients": "Pénicilline v potassique",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185690,
    "drug": {
      "current_status": "MARKETED",
      "id": 9944,
      "drug_code": 6421,
      "updated_date": "2025-12-03T00:30:23-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250893,
          "ingredient": {
            "id": 1816,
            "ingredient_code": 8426,
            "en_name": "PENICILLIN V POTASSIUM",
            "fr_name": "Pénicilline v potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00642215",
      "brand_name": "PEN-VK",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63031",
      "number_of_ais": "1",
      "ai_group_no": "0105897011"
    },
    "created_date": "2023-02-28T18:20:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00642215",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01CE",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "anticipated_start_date": "2023-03-03T00:00:00-05:00",
    "estimated_end_date": "2023-05-19T00:00:00-04:00",
    "actual_end_date": "2023-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-13T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PEN-VK",
    "en_drug_common_name": "PEN-VK",
    "fr_drug_brand_name": "PEN-VK",
    "fr_drug_common_name": "PEN-VK",
    "en_ingredients": "PENICILLIN V POTASSIUM",
    "fr_ingredients": "Pénicilline v potassique",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185693,
    "drug": {
      "current_status": "MARKETED",
      "id": 10996,
      "drug_code": 66985,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254134,
          "ingredient": {
            "id": 176,
            "ingredient_code": 8452,
            "en_name": "TRIMETHOPRIM",
            "fr_name": "Triméthoprime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243116",
      "brand_name": "TRIMETHOPRIM TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114346001"
    },
    "created_date": "2023-02-28T18:21:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243116",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01EA",
    "atc_description": "SULFONAMIDES AND TRIMETHOPRIM",
    "anticipated_start_date": "2023-02-28T00:00:00-05:00",
    "estimated_end_date": "2023-04-10T00:00:00-04:00",
    "actual_end_date": "2023-03-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-30T20:21:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRIMETHOPRIM TABLETS",
    "en_drug_common_name": "Trimethoprim",
    "fr_drug_brand_name": "Trimethoprim",
    "fr_drug_common_name": "Trimethoprim",
    "en_ingredients": "TRIMETHOPRIM",
    "fr_ingredients": "Triméthoprime",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185698,
    "drug": {
      "current_status": "MARKETED",
      "id": 31896,
      "drug_code": 944,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250221,
          "ingredient": {
            "id": 672,
            "ingredient_code": 11107,
            "en_name": "DOXEPIN",
            "fr_name": "Doxépine (Chlorhydrate de doxépine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00024325",
      "brand_name": "SINEQUAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "32891",
      "number_of_ais": "1",
      "ai_group_no": "0107703006"
    },
    "created_date": "2023-02-28T18:23:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00024325",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2023-03-13T00:00:00-04:00",
    "estimated_end_date": "2023-05-02T00:00:00-04:00",
    "actual_end_date": "2023-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-01T15:50:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SINEQUAN",
    "en_drug_common_name": "Sinequan",
    "fr_drug_brand_name": "Sinequan",
    "fr_drug_common_name": "Sinequan",
    "en_ingredients": "DOXEPIN",
    "fr_ingredients": "CHLORHYDRATE DE DOXÉPINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185707,
    "drug": {
      "current_status": "MARKETED",
      "id": 50282,
      "drug_code": 94581,
      "updated_date": "2025-05-15T02:35:40-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8262184,
          "ingredient": {
            "id": 6505,
            "ingredient_code": 22816,
            "en_name": "EDOXABAN",
            "fr_name": "Édoxaban (Tosylate d'édoxaban monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458667",
      "brand_name": "LIXIANA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0158530003"
    },
    "created_date": "2023-02-28T20:13:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458667",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "B01AF",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2023-02-24T00:00:00-05:00",
    "actual_end_date": "2023-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-03-09T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LIXIANA",
    "en_drug_common_name": "ÉDOXABAN",
    "fr_drug_brand_name": "LIXIANA",
    "fr_drug_common_name": "ÉDOXABAN",
    "en_ingredients": "EDOXABAN",
    "fr_ingredients": "edoxaban tosylate monohydrate",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185710,
    "drug": {
      "current_status": "MARKETED",
      "id": 31404,
      "drug_code": 937,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250217,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": ".025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250216,
          "ingredient": {
            "id": 4126,
            "ingredient_code": 20254,
            "en_name": "DIPHENOXYLATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diphénoxylate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00036323",
      "brand_name": "LOMOTIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "32655",
      "number_of_ais": "2",
      "ai_group_no": "0203532001"
    },
    "created_date": "2023-02-28T20:17:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00036323",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "A07DA",
    "atc_description": "ANTIPROPULSIVES",
    "anticipated_start_date": "2023-03-15T00:00:00-04:00",
    "estimated_end_date": "2023-10-18T00:00:00-04:00",
    "actual_start_date": "2023-03-08T00:00:00-05:00",
    "actual_end_date": "2023-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-17T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOMOTIL",
    "en_drug_common_name": "LOMOTIL",
    "fr_drug_brand_name": "LOMOTIL",
    "fr_drug_common_name": "LOMOTIL",
    "en_ingredients": "ATROPINE SULFATE\r\nDIPHENOXYLATE HYDROCHLORIDE",
    "fr_ingredients": "Sulfate d'atropine\r\nChlorhydrate de diphénoxylate",
    "drug_strength": ".025MG\r\n2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 x 250's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185718,
    "drug": {
      "current_status": "MARKETED",
      "id": 10746,
      "drug_code": 66484,
      "updated_date": "2025-05-15T02:31:11-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8254068,
          "ingredient": {
            "id": 1012,
            "ingredient_code": 763,
            "en_name": "ENOXAPARIN SODIUM",
            "fr_name": "Énoxaparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.8",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242692",
      "brand_name": "LOVENOX HP",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PRE-FILLED SYRINGE 120MG/0.8ML",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131860002"
    },
    "created_date": "2023-02-28T21:15:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242692",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2023-03-20T00:00:00-04:00",
    "estimated_end_date": "2023-05-23T00:00:00-04:00",
    "actual_start_date": "2023-04-13T00:00:00-04:00",
    "actual_end_date": "2023-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-05-17T15:35:23-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "LOVENOX HP",
    "en_drug_common_name": "LOVENOX HP 120 MG / 0.8 ML",
    "fr_drug_brand_name": "LOVENOX HP",
    "fr_drug_common_name": "LOVENOX HP 120 MG / 0.8 ML",
    "en_ingredients": "ENOXAPARIN SODIUM",
    "fr_ingredients": "Énoxaparine sodique",
    "drug_strength": "120MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 185721,
    "drug": {
      "current_status": "MARKETED",
      "id": 3318,
      "drug_code": 18480,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252307,
          "ingredient": {
            "id": 1402,
            "ingredient_code": 215,
            "en_name": "DEXRAZOXANE",
            "fr_name": "Dexrazoxane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02153432",
      "brand_name": "ZINECARD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80739",
      "number_of_ais": "1",
      "ai_group_no": "0152586001"
    },
    "created_date": "2023-02-28T21:24:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02153432",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "V03AF",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "hc_updated_date": "2023-10-31T12:55:47-04:00",
    "actual_start_date": "2023-02-28T00:00:00-05:00",
    "actual_end_date": "2023-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-31T12:55:51-04:00",
    "status": "resolved",
    "hc_en_comments": "De-escalation from Tier 3 stats October 26, 2023.",
    "hc_fr_comments": "Désescalade des statistiques de niveau 3 le 26 octobre 2023.",
    "en_drug_brand_name": "ZINECARD",
    "en_drug_common_name": "ZINECARD",
    "fr_drug_brand_name": "ZINECARD",
    "fr_drug_common_name": "ZINECARD",
    "en_ingredients": "DEXRAZOXANE",
    "fr_ingredients": "Dexrazoxane",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]